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Abstract
Background. Patients under general anesthesia have a risk of regaining
awareness while being paralyzed and unable to communicate, which may
lead to severe psychological trauma. Various methods for monitoring the
depth of anesthesia are available, but they rely on measuring biological
markers that may be misleading. A new method has been suggested:
using a brain computer interface to detect if the patient is attempting to
move, because cortical activity as a result of attempted movement can be
measured reliably. A system for detection of intraoperative awareness
must have a simple generic hardware montage that takes a minimal
amount of time to set up, in order to be considered clinically feasible.
Electroencephalography (EEG) and functional near-infrared spectroscopy
(fNIRS) are two methods for measuring brain activity, which exhibit
different advantages and disadvantages. This study investigates if fNIRS
may be considered a feasible alternative.
Methods. A combined EEG- fNIRS measurement experiment was con-
ducted on freely informed participants. The participants performed ran-
domly selected, hand and foot movement tasks while brain activity was
measured. The data was analyzed post hoc to determine, and compare
the performance of the two modalities at detecting these movements.
Results. The average performance rate for EEG at detecting movement,
both hand and foot, was higher than for fNIRS, although only significantly
for foot movement. Observations made during the analysis suggests
that fNIRS could not measure foot movements reliably, and that the
performance for the two modalities at detecting hand movements were
mutually exclusive, suggesting that only one modality could measure
hand movement reliably at a time.
Conclusion. The author will argue, based on aforementioned observa-
tions, that using fNIRS or a combination of EEG and fNIRS, in an intra-
operative awareness monitoring system reliably, will increase the time an-
d/or complexity of the setup, making it less feasible than a system based
on EEG alone. Further research is needed to verify this argument.
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Chapter 1
Introduction and motivation
Patients undergoing surgery under general anesthesia have a risk of re-
gaining awareness while being paralyzed and unable to communicate.
This might be traumatizing to the patient and may lead to late psycholo-
gical effects like anxiety, sleep disturbances and post traumatic stress dis-
order. Various methods for monitoring the depth of anesthesia are avail-
able, but they rely on measuring biological markers that may be mislead-
ing.
An ongoing research project at the Donders Institute for Brain,
Cognition and Behavior suggests an alternative approach; to detect if
the patient is trying to move, since this is a natural response for a
patient experiencing anesthesia awareness, and attempted movement can
be detected reliably with a brain-computer interface (BCI). The system
proposed by Donders Inst. is based on measuring the electrical impulses
produced in the brain (EEG) when attempting to move. Another method
of measuring the brain’s activity is functional near infra-red spectroscopy
(fNIRS, sometimes denoted as NIRS in more technical context), which is
based on measuring the oxygen consumption of particular areas in the
brain. These two methods have different advantages and disadvantages.
This study will investigate if fNIRS can be considered a feasible
alternative to EEG in regard to how well the two systems can detect
attempted movement, and if the system can operate with a minimal,
generic setup that will work for all patients. To investigate this a volunteer
study with a minimum of 10 healthy participants will be conducted. The
participants will be wearing a combined EEG and fNIRS system while
performing movement tasks. The gathered data will be analyzed to
determine if the system meets the requirements, and whether or not the
classification rate of detecting movement will exceed the classification rate
of the EEG-based system.
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1.1 General anesthesia
When a patient has to undergo surgical treatment, there is often a need to
induce unconsciousness so that the patient does not feel or recall any of
the procedure. A specially trained medical doctor, the anesthesiologist,
will administer several types of medications, in succession, to the
patient before the surgical procedure, the basic components being a)
a hypnotic component which induces a state of unconsciousness and
prevents the formation of memory (amnesia), b) an analgesic component
which prevents sensation of pain and stops autonomic reflexes, and c)
a neuromuscular blocking agent which paralyzes the patient to prevent
any muscular contractions which may complicate the procedure. This
combination will lead to a state of unconsciousness not unlike medically
induced coma. [1]
When the medications are administered the anesthesiologist will
observe the different stages of anesthesia listed below [2]:
• Induction - the patient is able to talk, but slowly loses consciousness.
• Excitement - the patient’s muscles begin to convulse, and heartbeat
is irregular. This stage passes quickly, and after this stage the patient
will have lost consciousness completely.
• Surgical anesthesia - at which the patient’s skeletal muscles begin to
paralyze and eye movement stops. At this stage the patient is ready
for surgery.
• Overdose - this stage is reached if the patient receives too much
medication, and may lead to severe brain stem or medullary
depression, which can be fatal.
When the patient has reached the stage of surgical anesthesia, the
procedure may begin. In this state the patient is often totally paralyzed,
unresponsive to reflex activation, and in need of assisted breathing and
monitoring of vital organs.
The anesthesiologist’s task at this stage is to monitor and balance
the administration of the different anesthetics components to keep the
patient anesthetized and prevent overdosing. This is typically done
by monitoring heart rhythm (ECG), blood oxygen saturation (SpO2),
concentration of medication, carbon dioxide levels from expiration, blood
pressure and temperature. Additionally there will, in some cases, be some
form of awareness monitoring.
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1.2 Intraoperative awareness
Undergoing surgery with general anesthesia is not without risks. Many
adverse effects may happen in regards to anesthesia as a result of
wrongful administration of drugs, human error or imprecise monitoring.
One of these adverse effects is a phenomenon called intraoperative
awareness (IOA), which manifests in a state where the patient has
regained awareness while under surgery, but due to neuromuscular
blocking agents is not able to communicate and make the surgery staff
aware of the problem. [3, 4, 5, 6]
A prospective, non-randomized cohort study conducted by Sebel at
al. [3] on 19,575 patients at seven medical centers in the United States
identified 25 cases (0.13%) of awareness occurring at a rate of 0.1-0.2% at
each medical facility. Another study conducted by Errando et al. [5] report
a number of incidents as high as 1% . The data used in intraoperative
awareness studies are often based on different methods of interviewing
the patients [7], which might explain the large variation. Nevertheless,
IOA is a problem which must be taken seriously, and methods for
prevention have a potential for improvement.
1.2.1 Cause
A review study conducted by Ghoneim et al. [4] argues that the number of
cases that are reported in prospective studies are insufficient to identify the
risks, casual factors and sequelae and they therefore reviewed published
cases —from the very first in 1950 to 2005. Comparing 271 reported cases
of anesthesia awareness against 19504 control cases without awareness,
they found that patients experiencing awareness were more likely to be
female, young and to have undergone cardiac and obstretic surgery. They
received fewer anesthetic drugs, and were more likely to have episodes
of tachycardia and hypertension. The most common causes of anesthesia
awareness is a patient history of awareness, in addition to small anesthetic
doses and light-anesthetic techniques used as a precautionary measure on
sicker patients undergoing major surgery [3, 4, 5].
1.2.2 Recollection
Although more cases of awareness are reported when using the isolated
arm technique (which is done by putting a cuff on the patients arm before
administering neuromuscular blocking agents so that the patient may
move the arm if aware), many of these patients do not recall the events
when interviewed after the operation [8].
Explicit memory is the conscious recollection of events that occur,
while implicit memory can be described as the changes in behavior
produced by occurring events without necessarily recollecting what has
3
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happened. Explicit recollection of awareness is the leading factor for
adverse psychological sequelae, but it is conceivable that the implicit
memory formation can contribute to this. Although implicit memory is
unlikely to cause major psychological problems, the patient might be more
anxious and unhappy than they would be otherwise. [8]
Implicit memory formation might be unavoidable, but better monitor-
ing of the patient’s mental awareness state might reduce the number of
incidences with explicit memory formation and reduce the psychological
trauma that is caused.
1.2.3 Sequelae
Experiencing awareness with recall during surgery can be a horrific
experience, and in 34% of the reported cases, the patient describe a feeling
of helplessness, anxiety, panic, impending death or catastrophe during the
episode. This is very traumatizing, and may have adverse postoperative
sequelae. 48% of the patients that experienced awareness with recall later
reported sleep disturbances, nightmares, daytime anxiety, fear of future
anesthetics and other late psychological effects [4].
Although this is a rare phenomenon, the sequelae may be severe and
leave patients depending on mental health care for an extended period
after surgery as a result of symptoms resembling post traumatic stress
syndrome. [4, 9, 10]
1.2.4 Methods for preventing IOA
Methods for preventing intraoperative awareness currently rely on monit-
oring the physiological factors related to anesthesia. The anesthesiologist
will monitor vital signs and different techniques are used in the attempt
to monitor the depth of anesthesia, one of which is the Bispectral index
(BIS, Aspect Medical Systems, Newton, MA, USA). BIS combines EEG
and EMG to estimate the depth of anesthesia based on empirically derived
parameters. The index ranges from 0 to 100 where 100 is fully awake and 0
is no EEG signal. The recommended value is between 40 - 60 for adequate
depth of anesthesia.
Although BIS was the first available technique for monitoring the
depth of anesthesia, and the most frequently used1, its reliability is
disputed. Case studies have reported incidents where the patient has
experienced AWR even though they have been in the recommended range
of BIS [11] and that the BIS monitoring measures EMG alone instead
of depth of anesthesia, which resulted in increased BIS value although
concentration of anesthetics was increased [12]. A study by Avidan et al.
1http://investor.covidien.com
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[13] argues that routine BIS monitoring does not reduce the number of
AWR incidences.
Monitoring depth of anesthesia based on measuring auditory evoked
potential has also been attempted (A-Line AEP index, AAI), but several
studies has shown that it performs even less successfully than BIS and
that further improvements are required [14, 15, 16, 17].
The various methods of monitoring depth of anesthesia available today
focus on the changes in neural activity as the anesthesia takes effect.
Neural correlates to consciousness and awareness have not yet been
found, so these monitors are therefore not reliable [6]. A new way to
address this problem is clearly needed.
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1.3 Brain-Computer Interface
The idea behind a brain-computer interface (BCI) is to create a link
between the brain and the environment around the user using thought
alone, a communication that bypasses the normal channel of using the
peripheral nervous system and muscles to communicate or move around.
This can be managed by continuously measuring the brain signals and
predicting the user’s intentions based on the features hidden within these
signals. The predictions can then be used to control a computer which, in
turn, performs the desired actions. [18, Chap. 1]
The advances in cognitive neuroscience research have led to a greater
understanding of the brain signals and the features they exhibit. The de-
ciphering of these signals is not yet complete, but important components
can be extracted and used for different purposes. Creating an interface
between brain and machine can be done by harnessing these signals, ex-
tracting the features within them and predicting what they mean. [19]
1.3.1 Applications
A BCI can be used for a number of different purposes ranging from
recreational use like controlling games and virtual reality to rehabilitation
and making life easier for people who cannot make use of their peripheral
nervous system. A BCI will harness the brain signals straight from
the source and is therefore promising with regards to helping patients
who have no muscle control and therefore cannot communicate through
normal channels. BCI controlled prosthetics [20], wheelchairs [21, 22],
spelling programs [23, 24], and environment control are just a few
examples of this.
Some BCI applications demand only a binary selection, for example to
turn something on or off. A binary switch system with the use of BCI does
not demand great resolution, especially spatial resolution. This makes it
possible to limit the number of electrodes being used and as a result it
will shorten the setup time and the time it takes to train the algorithm. A
binary control system can, for example, be utilized to sound an alarm. [25]
The recent improvements of consumer grade EEG devices2 has
resulted in a massive increase in promising and exciting new BCI
applications. Neuro-gaming, for example, is becoming an area with
increased growth, with it’s own conference exposing many innovative
ways of incorporating BCI technology into the entertainment industry3.
2Emotive Systems, NeuroSky, Interaxon
3www.neurogamingconf.com
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1.3.2 The BCI cycle
The principle of a BCI-system is that it is a continuous loop or cycle
that starts and ends with the user. Figure 1.1 and 1.2 on the next page
are representations of this cycle from Van Gerven [19] and Shih et al.
[26] respectively. The cycle begins by measuring brain signals while the
user is performing a mental task and the signals are preprocessed to
remove artifacts before the interesting features are extracted. A classifying
algorithm predicts what the user intends based on a mathematical model,
and the prediction is presented back to the user by some form of sensory
feedback (visual, auditory and/or tactile). [19, 26, 18]
Figure 1.1: Representation of the BCI cycle, from Van Gerven et
al. [19]. The measured signal is preprocessed to eliminate noise
and artifacts, the features that distinguish the intent of the user
is extracted and an algorithm makes a prediction based on these
features. The predicted outcome is presented back to the user
and is used to determine the success by checking if it was the
true intention of the user.
7
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Figure 1.2: Representation of the BCI cycle, from Shih et al. [26].
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Signal acquisition and measurement technology
The first step in the BCI cycle is to measure the user’s brain signals.
There are several methods for acquiring brain signals for assessing cor-
tical activity, and they can be separated into technologies based on meas-
uring electophysiological signals, indirectly measuring the hemodynamic
response, i.e. the oxygen consumption within the cortex, or measuring
magnetic fields. They are also usually separated into invasive and non-
invasive methods.
Methods used for measuring electrical signals are electroencephalo-
graphy (EEG), electrocorticography (ECoG), microelectrode (ME) or mi-
croelectrode array (MEA), and local field potentials (LFP). The concept
behind this type of measurement is that it measures the electrical poten-
tial which is produced by the ionic currents caused by firing axons in the
neurons. The neuronal activity can be measured at different location or
scale depending on the purpose, for example the microelectrode array
will measure a very small area directly within the cortex, the electrocor-
ticography will measure a large area of the brain with electrodes placed
between the dura mater and cortex while EEG will measure the electrical
potential that reaches the scalp, see figure 1.3. [18, Chap. 9]
Figure 1.3: This diagram is showing the placement of different
measurement modalities in a coronal cross section of the human
head. Electroencephalography (EEG) electrodes and functional
near-infrared spectroscopy (fNIRS) optodes are placed on
the scalp, electrocorticography (ECoG) electrodes are placed
epidural or subsural under the skull, micro electrodes (ME),
micro electrode arrays (MEA) and local field potential (LFP)
electrodes are placed directly within the cortex.
9
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The invasive methods for acquiring brain measurements gives it a very
high signal to noise ratio and resolution, both temporal and spatial, but it
carries all the risks that implants and brain surgery entail. The invasive
methods are therefore best suited for long term users. See figure 1.4 for an
overview of the different measurement technologies and their respective
resolutions.
Figure 1.4: Spatial and temporal resolutions of various methods
of measuring brain signals. Invasive methods are shown in red
and non-invasive in blue. From Van Gerven et al. [19]. The
invasive methods have better resolution than the non-invasive
in both spatial and temporal resolution.
Methods measuring the hemodynamic changes are functional near-
infrared spectroscopy (fNIRS), positron emission tomography (PET) and
functional magnetic resonance imaging (fMRI), the concept being that it
measures the metabolic rate in the cortical area of interest. The metabolic
rate is an indirect sign of cortical activity because the neurons that fire
consume more oxygen. PET uses a radioactive tracer which, when injected
into the subject, will locate the areas of increased metabolic rate, while
fMRI creates an image of tissue based on the amount of hydrogen atoms
and measures blood flow and oxygenation by utilizing the blood oxygen
level dependent (BOLD) contrast. fNIRS utilizes the absorption of near-
infrared light through tissue to measure the concentration of oxygenated
and de-oxygenated hemoglobin, and thereby assess the metabolic rate in
the cortical areas of interest. [18, Chap. 9]
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Although both PET and fMRI can be very useful in BCI research
they are too cumbersome and expensive for most BCI applications. The
temporal resolution is also very low. fNIRS measurement equipment, on
the other hand, is fairly inexpensive and portable while measuring the
same hemodynamic changes at the cost of lower spatial resolution.
For brain-computer interfacing the methods of measuring brain signals
differ based on the resolution needed for the intended application. Some
of the methods require equipment which is too big, expensive and
cumbersome to be a feasible alternative in many applications, so the
majority of BCI research uses EEG since it has a good temporal resolution
[27] and is fairly cheap and portable compared to fMRI, PET and other
methods requiring large equipment. The fact that it is non-invasive also
makes it a good alternative for short term users.
Signal preprocessing
The electrical brain signals measured with EEG contain considerable noise
and artifacts which is caused by electrical interference, myoelectrical
activity from eye blinks and movement which has to be removed to get a
clear signal which, in turn, can be used for feature extraction. For electrical
measurements the data will usually be filtered and the common average
potential will be removed, which removes most of the external noise
and interference. A reference electrode placed near the eye, recording
myoelectrical potential, might also be used to subtract the electrical signal,
caused by movement artifacts, from the measurements.
For hemodynamic signals measured with fNIRS the response is slow
(approx. 0.2Hz [28]) and high frequency noise can easily be removed with
a lowpass filter. The slow drifts are removed with a highpass filter and the
use of a reference channel can improve the signal to noise ratio further by
subtracting the hemodynamic signal from more shallow tissue like scalp
and skull [29].
Feature translation
The features that are hidden in the neurological signals must be translated
into meaningful commands to be further processed. This can be done by
using an algorithm based on a mathematical model which describes the
relationship between the intent of the user and the set of features the signal
exhibits. The mathematical models can either be discriminant or based
on regression. A discriminant model will translate the observations into
discrete categories of output whilst a regression model will translate the
features into a continuous variable. [18, Chap. 8]
The algorithm must be trained to recognize the different outputs, called
classes. During a training block, the user is told what to do while the data
is recorded, in this way the intentions of the user, i.e. classes, and the data
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associated with them are known. Given this information a linear logistic
regression model will calculate the feature coefficients based on the known
output. [30]
The feature coefficients are saved as a classifier for that particular user
during that particular session. Think of this classifier as the function that
relates the data to the output, or class, that is associated with it. The
classifier can then be used on further data recordings to predict the output,
analogous to a decryption key used on encrypted data.
Biological data has a high degree of variation, so to be sure that the
algorithm will perform well on future data it needs to be tested with data
other than the data used to parameterize it. This is done by separating
the data into a training set and a test set. The training set is used to
parameterize, i. e. make a classifier, and the classifier is applied to the
test set to evaluate the performance. To further improve the evaluation
the data is divided into subsets using one subset for training and the rest
for testing. This cross validation is done X-fold (10-fold used in this study)
meaning that all except one subset (X-1) is used to train a classifier and
then tested on the remaining subset, this is done for each subset. After
the performance tested on each subset has been evaluated the score is
averaged over all folds and the best one is a measure of the performance
where 1.0 is perfect discrimination between classes and 0.5 is random
chance, i. e. the classifier can not predict the users intent. [18, Chap.
8]
Neurological signal features
The brain signals will show different patterns based on what the person
is thinking or what sensory input the person is subjected to. For example,
when a person moves the right arm, or even imagines to move the right
arm, there is a change in the power spectrum of the sensorimotor rhythms
(SMR) recorded on the motor cortex in the left brain hemisphere. This
is an example of an induced signal feature meaning that the response
is produced by the user actively thinking about something, in this case
movement. Another example: when a person is subjected to a sequence of
short sounds, where a few of the sounds are of a different pitch (called an
oddball paradigm [31]), an event related potential (ERP) can be detected
as an increase in amplitude approximately 300 ms after the odd sounds
(P300). This is an example of an evoked response meaning that the feature
is produced as a response to external stimulus. Another evoked response
worth mentioning, is the steady state visually evoked potential (SSVEP)
which, when recorded on the visual cortex, will show the same repeating
structure in the brain response as a regularly repeating stimulus presented
to the user. Since this study is focusing on SMRs and hemodynamic
responses as a result of movement, the evoked responses will not be
introduced further.
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Figure 1.5: Diagram showing a coronal cross section of the
motor cortex homunculus, from Penfield and Rasmussen [32].
It shows the cortical areas in the motor cortex which is
associated with movement of different parts of the body. Note
that the location for foot movement is further from the skull
than hand movement.
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SMRs are electrical oscillations that can be recorded over the sen-
sorimotor cortices, figure 1.5 on the preceding page is Penfield and
Rasmussen’s [32] representation of the motor cortex and the areas asso-
ciated with movement of different body parts. The oscillations that EEG
can detect are in the frequency groups of the mu-band (8-12 Hz) and the
beta-band (18-30 Hz). When a person is moving, or imagining a move-
ment, the power of these frequencies will decrease. This is called an event
related desynchronization (ERD) and is a clear correlate to the users intent
to move. Immediately after movement, or imagined movement, the SMR
may increase and this is called an event related synchronization (ERS).
These responses can be clearly identified by looking at a time-frequency
plot of the power spectrum, see figure 1.6. [18, Chap. 13]
Figure 1.6: Time frequency plot of sensorimotor rhythmic
ERD/ERS recorded near the motor cortex (CP3, 10-20 electrode
position system [33]). Blue and red represents a decrease and
increase in frequency power respectively. Task duration is, in
this case, from 0 - 15 s and a clear ERD/ERS pattern can be seen
for the mu (8 - 12 Hz) and beta (18 - 30 Hz) bands. This plot is
from Blokland et al. [28] and it is used here only to illustrate a
typical SMR response.
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The hemodynamic response is another feature that correlates to cortical
activity. When neural activity increases, the demand for oxygen is
increased in the relevant area. This blood oxygen level dependent
(BOLD) response is a change in concentration of oxygenated (HbO) and
de-oxygenated (HbR) hemoglobin and can be detected as a change in
amplitude of the optical density through the cerebral cortex. This is
explained in detail in section 1.4 on page 17.
1.3.3 BCI in intraoperative awareness detection
When moving or attempting to move parts of the body the neural activity
will increase in the respective areas of the motor cortex, see figure 1.5 on
page 13. The electrical signals produced in these areas will have features
that distinguish between relaxation and attempt to move. A brain-
computer interface translates these signals into control signals which can
be used for different purposes, in this case to give a signal if the patient
is trying to move. There are several different methods for acquiring brain
signals (e.g. EEG, fMRI, ECoG, PET, fNIRS), each with its own advantages
and disadvantages. For this purpose ECoG, ME and MEA can be excluded
since they are invasive, fMRI and PET can be excluded due to the size and
cost of the equipment/procedure which leaves EEG and functional near-
infrared spectroscopy (fNIRS).
An on-going research project at Donders Institute for Brain, Cognition
and Behavior4 suggests an alternative to existing methods: using a brain-
computer interface (BCI) to detect if the patient tries to move his or her
limbs, rather than monitoring the depth of anesthesia, since trying to move
has consistently been reported by patients experiencing intraoperative
awareness and attempted movement has clear neural correlates which can
be detected reliably.
Blokland et al.[6] further suggests requirements for this system to
be clinically feasible: The system must have a standardized setup of
electrodes which must work for all patients. The algorithm for decision
making must have a very low false positive rate and a high true positive
rate. The acceptable rate of false positives is one per 2 hours operating
time and the time to detect awareness must not exceed 2.5 min. Although
this may increase the reaction time for the system, the accuracy is here
prioritized over speed, considering that the anesthesiologist must remain
focused at all times and that more than one false alarm during 2 to 3
hours operating time does not seem to be clinically acceptable according to
Blokland et al.’s experience. The suggested detection paradigm is a "four-
in-a-row" selection which means the system must detect four attempted
movements in a row to set of the alarm –this will lower the chance for
false positive detections. Ideally, the system would be asynchronous, but
4Radboud University, Nijmegen, the Netherlands
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this establishes a much more complicated signal processing procedure. A
synchronous model is therefore suggested using an auditory cue to time
lock the task, i.e. the patient must attempt movement in sync with an
auditory cue.
EEG is the most commonly used measurement technology in BCIs
because it has a high temporal resolution which makes it fast enough
for real-time processing and able to detect frequency changes with high
accuracy. These features, however, may not be that important in a
system for detecting intraoperative awareness where the only necessary
distinction is between attempted movement and no movement. fNIRS,
which has a lower temporal resolution than EEG but can measure brain
activity with a smaller number of channels, and may therefore be a feasible
alternative to EEG in this application.
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1.4 Functional near-infrared spectroscopy (fNIRS)
Functional near-infrared spectroscopy is, as previously mentioned, an
alternative method of indirectly assessing cortical activity by measuring
the haemodynamic response (much similar to fMRI) rather than electrical
activity [34]. By emitting near-infrared light into the scalp and measuring
the reflected light it is possible to determine the amount of blood
oxygenation and thereby measure the oxygen consumption of activated
neurons in a particular area of the brain. This measurement technique has
been implemented in BCI applications, both as an alternative to EEG [25],
and as a combination of the two resulting in a hybrid BCI-system [28, 35].
1.4.1 Hemodynamics
When neurons create action potentials the demand for energy increases,
and more oxygen is consumed. This increase in regional cerebral
metabolic rate of oxygen consumption (rCMRO2) will change the regional
cerebral blood flow (rCBF) and result in an increase of oxygenated
hemoglobin (HbO) and a decrease of de-oxygenated hemoglobin (HbR)
as the cortical region is active [27]. After the region stops being active
the hemoglobin levels will fall back to baseline within a few seconds.
This response is often called the blood oxygen level dependent (BOLD)
response and a typical response can be seen in figure 1.7 on the following
page.
During movement or imagined movement the corresponding area
of the motor cortex will accelerate its metabolism, which results in an
increase of venous HbR, the vascular system responds by dilating to
increase the flow of oxygenated blood to prevent oxygen deprivation in
the area and supplies more oxygen than needed, the HbR level drops
significantly and the level of HbO rises [36]. An attempted movement
can thereby be classified by measuring a decrease of HbR and an increase
in HbO by a 2- to 3-fold magnitude [37].
1.4.2 Signal acquisition
Near-infrared light ranges from 700 nm - 1000 nm in the optical spectrum
and has the ability to pass through tissue like skin and bone and reach the
cerebral cortex if projected into the scalp. The light will scatter through the
tissue and some of it will be absorbed by chromophores (light absorbing
molecules) like oxygenated and de-oxygenated hemoglobin. The light
that is reflected will be picked up by a receiving fiber optic cable and
transported to a photomultiplier amplification. The signal is then digitally
converted and can be further processed, see figure 1.8 on page 19. [18, 38,
25, 39, 34, 37]
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Figure 1.7: A typical BOLD response to motor stimulation dur-
ing actual movement of the hand. The BOLD response to ima-
gined movement will show a similar characteristic, although
less prominent. The motor stimulation cue is, in this case, from
0 - 15 s, marked with yellow. The concentration of oxygenated
hemoglobin (HbO) will increase as the stimulation progresses
while the de-oxygenated hemoglobin (HbR) concentration will
decrease, although to a lesser extent. Note that the BOLD re-
sponse is rather slow, taking approx. 7 - 10 seconds to reach
peak value and approx. the same to return to baseline after
stimulus ends.
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Figure 1.8: Components of a continous wave fNIRS system,
from Coyle et al. [25]. The signal generator produce a sinus
signal which is sent into the scalp as light through an optode.
A receiving optode picks up a portion of the light which scatters
through the tissue and sends it to a photo amplification unit. A
lock-in amplifier extracts the signal and removes the common
noise and the data is digitally converted for further processing.
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The absorption spectra, within the NIR range, of oxygenated and
deoxygenated hemoglobin, as seen in figure 1.9 by Rolfe [40], has a distinct
difference and by sending beams of light at two different wavelengths, one
on each side of the isobestic point (the frequency where absorption is equal
for both chromophores), the chromophores can be measured individually.
Figure 1.9: Absorption spectra of chromophores in tissue, from
Rolfe. [40]. By applying the modified Beer-Lambert law to
measurements done with light frequencies on each side of the
isobestic point, the concentration of HbO and HbR (HbO2 and
HHb in this figure) can be extracted.
There are three different techniques for fNIRS measurements which
utilizes different properties of the absorption of light through tissue:
1. Time resolved spectroscopy which uses a pulse of light to measure
how much time the photons use to get through the tissue.
2. Frequency domain spectroscopy measures both the phase delay and
attenuation of the reflected light, by using intensity modulated light.
The phase delay is related to the time delay through the tissue and
the path length can be calculated.
3. Continuous wave spectroscopy uses a continuous emission of light
modulated at low frequency, the changes in magnitude in the
received light is a measure of absorption in the tissue.
Although the first two methods can give more information like better
depth resolution and measurement of the path length, the instrumentation
is much more complex and expensive and the continuous wave method is
therefore most commonly used. [25, 27]
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1.4.3 The modified Beer-Lambert law
The absorption of light through matter is described by the Beer-Lambert
law and relates the transmission of light to a product of the matter’s
absorption coefficient and the distance the light travels. This, however, is
only applicable in a setting where the absorbing matter is homogeneous,
does not scatter the radiation, and light is projected straight through the
matter (often through a cuvette). The layers of tissue from scalp to cortex is
much more complex than a liquid or gas sample in a cuvette, and the light
beam is scattered by different interfaces and absorbed by several different
chemical compounds. fNIRS does not measure straight through the tissue,
but utilizes this back-scattering in order to get an elliptical beam of light
from the receiver to the transmitter, which are placed ipsilaterally next to
each other. [40]
A modified Beer-Lambert equation which takes the aforementioned
into account is therefore applied to convert the optical density data to
changes in hemoglobin. From Coyle et al.[25] “The attenuation due to
absorption and scattering effects may be described by a modified version
of the Beer–Lambert law:
A = log10
lo
l
= αcLB + G (1.1)
where A is attenuation, Io is the incident light intensity (mW), I is
the transmitted light intensity (mW), α is the specific extinction coefficient
(mol-1 m-1), c is the concentration of the absorber (mol), L is the distance
between the source and the detector (m), B is the differential path length
factor and G is a term to account for scattering losses.”
The differential path length factor (DPF) differs according to age and is
calculated individually for each subject based on an empirical study [41].
The attenuation, A, is also referred to as optical density (OD).
A multivariate analysis can be used to calculate the concentration
of both chromophores by assuming that the total attenuation at each
wavelength is equal to the sum of the attenuations of each absorber [40].
Coyle et al. [25] implemented an algorithm to calculate the changes in
hemoglobin based on an algorithm by Cope and Delpy [42] which relies
on the modified Beer-Lambert law and is the same principle for measuring
fNIRS used in this study:
∆A = (αHbO∆cHbO + αHbR∆cHbR)BL (1.2)
where ∆A is the change in optical density, αHbR and αHbR are extinction
coefficients for the two chromophores, B is the differential pathlength
factor and L is the distance between transmitter and receiver. By applying
this algorithm to two wavelengths on each side of the isobestic point the
changes in concentration of HbO and HbR can be extracted.
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1.4.4 Advantages and disadvantages
fNIRS, compared to EEG, has a greater latency (range of seconds) and
more limited spatial resolution (cm range), but it may have advantages
in that it is unaffected by the immense electrical noise within a clinical
environment since the measurement is optical as opposed to electrical, and
that it can be used inside an MRI. It may also have an advantage regarding
set-up time if the system can give reliable results with a smaller number
of sensors.
An estimated portion of EEG-based BCI users (15 to 30%) are "BCI-
illiterate" meaning that BCI control does not work for the user [43]. EEG-
based BCIs often require a lengthy training period where the user has
to learn a new thought process to control their brain’s electrical signals
reliably, which might cause this problem. The hemodynamic changes,
however, are directly coupled to the cognitive activity and is therefore
relatively easy for the user to control [38]. fNIRS may therefore be feasible
in that it may work for a larger portion of the population, although further
studies are needed to verify this. On the other hand, the optical signals
are affected by the hair color and the skull thickness of the user, which
decreases the signal to noise ratio. This may affect NIRSs ability to work
for the general population, since the signal to noise ratio will be decreased
for users with dark hair color or thick skulls. Experiments have also shown
that operation of a fNIRS-BCI under continuous background auditory
noise decreases the specificity by an average of 19% [44].
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1.5 Study goals and objectives
The goal of this study is to produce evidence on whether fNIRS may be
considered a feasible alternative to EEG for detection of intraoperative
awareness based on the fNIRS’s ability to detect attempted movement. In
addition to the criteria for clinical feasibility, that is, the optode setup must
be generic and working for all subjects, the false positive rate must not
exceed one per two hours working time and the time to detect awareness
must not exceed 2.5 min after the subject is trying to activate using a "four-
in-a-row" paradigm, i.e. four successful detected attempted movements in
a row.
The first objective is to assess the performance of EEG and fNIRS at
detecting actual hand and foot movement by measuring the classification
rates, as explained in section 1.3.2 on page 11. The classification rate is
a measure of the probability for true positive detection. It is essential
for an anesthesia monitor to perform well generically among patients,
the evidence will therefore be used to compare fNIRS to EEG which is
the gold standard in these kinds of BCI applications. The number of
participants is to small to verify the performance in a general population,
but the evidence produced can be used to argue the reliability of the two
modalities compared to each other.
The second objective will be to investigate if fNIRS has the ability
to discriminate between hand and foot movement using a center of
gravity (CoG) approach [45] to locate where the hemodynamic response
is originating. Although this may not be relevant for the implementation
of fNIRS in an anesthesia monitor where hand movement is enough, it
will give valuable insight into the spatial resolution of fNIRS based on
the specific optode setup that is used in this study. A minimal setup of
optodes/electrodes that works for the general population is essential for
this system to be clinically feasible. This study will, based on this objective,
hopefully be able to draw conclusions on whether or not a generic optode
setup can target the cortical area of interest reliably.
If a combination of fNIRS and EEG were to be used for anesthesia
monitoring, a standardized cap or fixture must be used to incorporate
both electrodes and optodes. This cap must therefore be placed on the
head according to the International 10-20 system for electrode placement
[33]. By calculating the difference in spatial location of center of gravity
between EEG and fNIRS (∆CoG), this will give a measure of how well
the two modalities agree on where the response is located. The 10-20
system, being the most established method for electrode placement, will
make EEG the most reliable source in this regard. Comparing ∆CoG with
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the performance of fNIRS will produce evidence as to whether or not the
difference in CoG affects the performance. If the ∆CoG anti-correlates with
the performance of fNIRS it will mean that optode placement is highly
individual, will affect the performance and the optodes can therefore
not be placed according to the 10-20 system. This may give additional
insight into the suitability of fNIRS when it comes to the importance of
optode/electrode setup.
To address these objectives three hypotheses will be stated:
• Hypothesis 1: fNIRS has a higher classification rate, i.e. the systems
ability to correctly predict the users intention, than EEG when
detecting movement of hand and feet.
• Hypethesis 2: The difference in location of center of gravity, i.e.
where the hemodynamic response originates, for hand and foot
movement will be significant when measured with fNIRS. The
location for hand movement is expected to be significantly more
lateral than the location for foot movement.
• Hypothesis 3: The difference in location of center of gravity, i.e.
where the brain signals originate, between EEG and fNIRS will anti-
correlate with the performance of fNIRS.
In addition to these objectives, a real time testing block will be per-
formed during the experiment to test if the system meets the requirements
of low false positive rate, and if it can detect a "four-in-a-row" activation.
This real time block is meant solely as a proof of concept.
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1.6 Study design
This is a basic research study to compare one type of signal acquisition,
namely fNIRS, to EEG for the end purpose of detecting intraoperative
awareness. A volunteer study was conducted in close collaboration
with the BCI research group at Donders Institute for Brain, Cognition
and Behavior at their facilities at Radboud Uni. in Nijmegen, the
Netherlands. The protocol and analysis procedures are based on similar
studies performed by Blokland et al. [6, 28] at this institute.
The volunteer study had to include a minimum of 10 healthy male and
female participants aged 18 - 60. The measurement devices used (TMSI
Mobita EEG, Artinis Oxymon NIRS) are non-invasive and electronically
safe according to several standards. The NIRS device is not CE-approved
as a medical device but has been declared to conform with all relevant
standards by the manufacturer, see Appendix A on page 81. The Donders
Inst. has laboratories set up specifically for BCI research with auditory
and electrically isolated rooms, a standardized system for enrollment of
voluntary participants and a research team with considerable expertise
regarding BCI research.
1.6.1 Sample size determination
BCI studies are usually novel and to prove a concept, the sample size is
therefore of less importance in most studies. Although the sample size is
usually accepted to be 10, it is here determined using binomial response
[46, Chap. 9]:
1. From Blokland et al.[6], it is assumed that the classification rate of
the EEG-based system is 92% , Ps = 0.92.
2. Second assumption is that the classification rate for the fNIRS-based
system will be over 75%, Pn = 1− 0.75 = 0.25.
3. The significance level is chosen to be 0.01 and the power to be 0.95
which gives a determination constant C = 17.8 . The sample size can
be determined from the following formula:
N =
Pn · (1− Pn) + Ps · (1− Ps)
(Pn − Ps)2 · C
=
0.25 · (1− 0.25) + 0.92 · (1− 0.92)
(0.25− 0.92)2 · 17.8
N = 10.35
N ≈ 10
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1.6.2 Inclusion criteria
The participant could be included given all of the following:
• Participant is willing and able to give informed consent for particip-
ation in the study.
• Male or Female, aged 18 to 60.
• Participant is in good health and has normal or corrected-to-normal
vision and hearing.
1.6.3 Exclusion criteria
The participant could not enter the study given any of the following:
• Participants who are hearing impaired. There were plans to use
auditory cues during the experiments, but it was later changed to visual
cues.
• Participants with any form of neurological impairment.
• Any other significant disease or disorder which, in the opinion of
the investigator, may either put the participants at risk because of
participation in the study, or may influence the result of the study, or
the participant’s ability to participate in the study.
1.6.4 Discontinuation/withdrawal of participants from study
Each participant had the right to withdraw study at any time. In addition,
the investigator could discontinue a participant from the study at any time
if the investigator considers it necessary for any reason, including:
• Ineligibility (either arising during the study or retrospectively
having been overlooked at screening)
• Significant protocol deviation
• Significant non-compliance with study requirements
• Consent withdrawn
1.6.5 Participants
The study was advertised at Radboud University5 and 16 participants
signed up. One participant failed the screening process and three
participants did not show up to the assigned timeslot. The twelve
remaining participants (7 female) was of age from 22-60 (mean 30 ±
10.3SD).
5SONA study participant system
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1.7 Data management and statistical analysis
No person-identifiable data other than the form for informed consent was
collected. Any participant with a deviation from the screening criteria was
not included and it was therefore not necessary to collected any data of
medical history for statistical analysis. The data collected from the trials
is linked to the participant through a non-decipherable code number and
can not be traced back to the participant. The data is stored on a server
located at the University of Oslo. The list of names with number codes,
along with the forms for informed consent is stored securely and is only
accessible to the head investigators.
1.8 Ethical considerations
The study was carried out in accordance with the World Medical
Association Declaration of Helsinki on Ethical Principles for Medical
Research Involving Human Subjects (Appendix C on page 87). Since
the study was carried out at Radboud Uni. in Nijmegen, Holland where
similar studies are approved and carried out at a daily basis, the protocol
was not sent to the Regional Ethical Commitee in Norway.
Although no adverse effects are anticipated, the well-being of the
participant takes precedence over all other interests. This is ensured
by seeking the potential participant’s freely-given informed consent, the
freedom to withdraw from the study at any time without prejudice, the
confidentiality of personal information and giving adequate information
about the study to the participant.
1.8.1 Informed consent
The participant had to personally sign and date the latest approved ver-
sion of the informed consent form before any study specific procedures
were performed. Written and verbal versions of the participant informa-
tion and informed consent was presented to the participants detailing no
less than: the exact nature of the study; the implications and constraints
of the protocol; the known side effects and any risks involved in taking
part. It was clearly stated that the participant is free to withdraw from the
study at any time for any reason without prejudice, and with no obligation
to give the reason for withdrawal.
The participant was allowed as much time as needed to consider
the information, and the opportunity to question the investigator or
other independent parties to decide whether they wanted to participate
in the study. Written informed consent was then obtained by means
of participant dated signature and dated signature of the person who
presented and obtained the informed consent. The person who obtained
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the consent was suitably qualified and experienced, and was authorized
to do so by the Principal Investigator. The original signed form is retained
at the University of Oslo. The forms are appended, see appendix D on
page 95.
1.8.2 Confidentiality
The investigators are subjected to strict confidentiality as per the regula-
tions stipulated by Oslo University Hospital. As mentioned in section 1.7
on the previous page the informed consent forms and all other personal
data is stored at a secure location only accessible to the head investigator.
The raw data from the trials are all anonymous and can not be traced back
to the participant.
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Methods
This chapter will introduce the tools and methods used to carry out the
experiment and data analysis for this study. As previously mentioned,
the objective of this experiment is to measure the brain activity that
is produced by hand and foot movement, using both EEG and fNIRS
simultaneously, for the purpose of comparing the two.
Using two measurement devices simultaneously is challenging. Cus-
tomized solutions must be implemented to ensure proper handling of
data, integration of hardware and software, and synchronization between
the individual data streams.
The fNIRS and EEG measurement devices had to be integrated phys-
ically by making a prototype cap, which is placed on the head of the par-
ticipants, incorporating both EEG electrodes and fNIRS optodes. This cap
ensures a uniform setup for all participants. The measurement devices’
recording software had no built in common platform for synchronization
of the two data streams, so a software buffer structure, explained in detail
in the next section, was used to handle all the data and sample markers
(also called events) to ensure proper synchronizations.
A software program exporting the EEG data from the measurement
software to the buffer continuously, was already available. This, however,
was not the case for the fNIRS measurement software. To solve this issue,
the author wrote a function that decrypts the binary output from the fNIRS
measurement software and exports it to the buffer continuously.
During the experiment sessions, brain activity is recorded while the
participant is asked to perform 15 second movement tasks (either hand
movement, foot movement or no movement), when visual cues are
presented on a monitor placed in front of the participant. Between each
trial there is a semi-random resting period to ensure that the brain signals
return to baseline (idle state). The tasks are randomly selected and evenly
distributed over 6 sequences of 6 trials, resulting in a total of 36 trials per
subject. The stimulus presentation, i.e. visual cues and instructions, were
implemented in Matlab [47] with PsychToolbox.
The data recorded with both modalities during the experiment sessions
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is processed and analyzed post hoc in Matlab, individually. Several
tools made specifically for analyzing brain signal data are used, most of
which are developed at Donders Inst., in addition to some written by the
author. The processed data is used to visualize the average recorded brain
responses among all subjects, and to determine the performance of the two
modalities.
2.1 Matlab toolboxes
FieldTrip is an open source Matlab toolbox developed at the Donders
Centre for Cognitive Neuroimaging which provides a high level interact-
ive environment for developing algorithms, data analysis and visualiza-
tion of numerous types of neuroimaging data. It is primarily intended for
electrophysiological data, like EEG, ECoG, etc., but it can be used on any
kind of time series data. It is therefore able to analyze hemodynamic data
like fNIRS. In addition to many tools for offline analysis of physiological
data, it is an environment for online real time processing which is ideal for
BCI research. [48]
Matlab is a single thread application, and though it is able to gather a
stream of real time data it is not able to gather the data and process it at
the same time. To solve this issue, the people behind FieldTrip developed
a buffer structure which is a cross between the acquisition of data and
the Matlab processing. The buffer receives the data and keeps track of
the sample number and timing, so that the Matlab data processing can
retreive data from the buffer at it’s own pace [48]. The FieldTrip buffer is
a TCP server and works like a blackboard structure —data and events can
be sent and retrieved from the buffer by several applications at once, see
figure 2.1 on the facing page.
The visual stimulus and on-screen instructions were written in Matlab
using the Psychophysics Toolbox developed by Brainard [49], Pelli [50]
and Kleiner et al. [51]. This toolbox is designed for low latency real time
visualization.
Most of the tools for data preprocessing and analysis are based on the
FieldTrip toolbox and further developed at Donders Inst. by Dr. Jason
Farquhar1. These tool are published under the GNU general public license
for open source software.
1github.com/jadref
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Figure 2.1: Diagram showing an example of a blackboard
structure. The buffer (blue square) acts as a common hub for
external programs. Other programs can read and write data
and events to the buffer and it will affect the other programs. In
this example the measurement data is sent to the buffer through
a driver, the stimulus script sends events when stimulus is
shown to the participant and the data processing script listens
to the buffer and starts processing when the events are written
to the buffer. The buffer will also send raw data to storage,
and a separate event handler can be implemented to perform
further actions when events occur.
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2.2 Hardware
fNIRS. The Oxymon MK III (Artinis, Zetten, the Netherlands) is a NIRS
measurement system that has two receivers and up to eight transmitters
and is shown in figure 2.2a on the next page. The Oxymon NIRS system is
not invasive or electrochemically connected to the research participant, the
intensity of the light source is under the threshold for harmful exposure,
and the device can therefore be considered safe in an investigative setting.
As previously stated, the device is not CE-approved as a medical device,
but has been declared to conform with all relevant standards.
Raw optical density data is recorded at 250 Hz, with two wave lengths
per channels (765 and 855 nm for HbR and HbO respectively). The
hardware has the option to include analog signals from external devices,
which was utilized to check the synchronization between the systems by
using a hardware marker, i.e. a short voltage pulse.
Connected to the device is fiber-optic cables which sends out and
receives near-infrared light. The device is capable of recording 16 channels
with the use of split fiber-optic cables, but only 2 split and 2 regular cables
were available resulting in a maximum of 8 channels, which in the opinion
of the author were sufficient.
EEG. The TMSI Mobita is a wireless EEG data acquisition system, and
is shown in figure 2.2b on the facing page. It is capable of transferring
32 channels of DC recording with a 24 bit data resolution over WiFi and is
CE-certified as a medical device (class 2A, type CF). The data was recorded
with a sampling frequency of 250 Hz.
The device is compact, battery-driven, portable and uses waterbased
electrodes, which makes the setup fast and relatively easy compared to
systems that use gel based electrodes. The cap that comes with this system
is flexible and relatively inexpensive, which was important for this study
since it had to be modified to incorporate both EEG and fNIRS without
having to decrease the number of electrodes.
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(a) Photo of the Artinis Oxymon NIRS data acquisition system.
(b) Photo of the Mobita EEG data acquisition system.
Figure 2.2: Photos of the hardware used in this study. a) Fiber
optic cables transmit and receive the near-infrared light. The
light is transmitted through the eight connectors on the right
and received through the two on the left. The device has the
capacity to transmit light through 8 channels if the transmitting
cables are split, in this study there were 2 split and 2 single
ended cables. b) 32 electrode channels measure data which is
received by the EEG data acquisition device. The data is sent to
a computer with WiFi.
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2.3 Optode/Electrode placement
The electrode placement follows the international 10-20 electrode place-
ment system [33]. The motor cortex, which is associated with movement
of the body, expands laterally from the central midline towards the ears.
The locations associated with hand movement is denoted with C3 and C4
for right and left hand respectively, see figure 2.3. The location associated
with foot movement is denoted with Cz. These are standard notations in
the 10-20 electrode system. The EEG electrodes are positioned to cover the
motor cortex on both hemispheres, while the fNIRS optodes are covering
the motor cortex on left hemisphere only, placed uniformly around C3.
Figure 2.3: Diagram showing the placement of optodes and
electrodes. The grey circles represent the EEG electrodes placed
according to the international 10-20 system. The red and
blue circles represent the placement of the fNIRS receivers and
transmitters respectively. The fNIRS receivers and transmitters
form 8 channels covering the left hemisphere motor cortex,
focusing on the center for right hand movement.
An already made EEG cap was modified to incorporate the fNIRS
optodes. The optodes and fiber optic cables are relatively heavy, so a
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styrofoam pad, approx. 1 cm thick, was glued to the inside of the fabric
with holes for the optodes and the electrode over C3, see figure 2.4 for
photos of the modified cap.
Figure 2.4: Photos of the modified cap with attached electrodes
and optodes. The cap was modified using a styrofoam pad
with holes placed underneath the fabric. This foam, approx.
1 cm thick, holds the optodes in place during the experiment.
A tooth pick was used to move hair to the side under the holes
before the optodes were placed, to achieve a better connection.
To ensure that the optodes were in contact with the scalp a band
was secured around the head, putting pressure on the optodes.
Hair under the holes for the optodes is moved to the side using a
toothpick before the optodes were placed and a band is fastened around
the subjects head to increase the pressure of optode to the scalp. This
ensures that the optodes are firmly placed with sufficient rigidity to be
in contact with the scalp during the experiment. A detailed view of the
optode setup is shown in figure 2.5 on the next page, showing how the
channels are formed.
Relying on the 10-20 framework may result in inaccuracies in optode
placement, and it is often necessary to adjust the placement manually
during a practice run until a detectable signal can be achieved. This is
not doable in this particular case since the optodes are incorporated into
the electrode cap. To counter this problem, the fNIRS channels have to
cover as much area as possible. The receivers and transmitters are spaced
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30 mm from each other with a 45◦ angle, which makes an area of coverage
at approx 44 x 88 mm around C3. This area of coverage is as large as
our equipment will allow, so to be sure that it covers the area of interest
the center of gravity is determined post hoc for the EEG, to see if the
location for the two movement conditions falls within the covered area.
From this analysis it will be determined if the difference between the two
CoG locations has any correlation to the performance for each subject.
Figure 2.5: Diagram showing the optodes and how the channels
are formed. The transmitters (blue circles) sends light which
scatters in the tissue beneath, some of this light is absorbed by
HbO and HbR and the rest is picked up by the receivers (red
circles). This results in a channel formed by the arched beam
of light between the transmitter and receiver that reaches the
cortex underneath. The optodes are placed uniformly around
C3, the area associated with hand movement, covering the
motor cortex strip.
2.4 Software integration
FieldTrip buffers, which is explained in section 2.1 on page 30, were used
to handle the events and the data from the EEG and fNIRS measurement
systems simultaneously. A driver for the Mobita to send the data stream
to the buffer was already available but there was no such driver for the
Oxymon. So to send the data from the Oxysoft measurement software
to the FieldTrip buffer, a program which translates the data and feeds
it to the buffer in real time had to be implemented. This was done by
decrypting a binary temp file, which is produced and constantly updated
by the Oxysoft data acquisition software during the measurement. After
comparing data read by the implemented program with the data from
Oxysoft a function run in Matlab which reads the data from the oxymon
and exports it to the FieldTrip buffer online was implemented, see
Appendix E.1 on page 101. The transfer rate is determined by the
operating system’s capacity to write to file and was in this case written
in blocks of 50 samples at a frequency of 5 Hz. Since the expected
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hemodynamic response in motor cortex is well under 1 Hz a 5 Hz transfer
rate is sufficient.
A representation of the software setup of this experiment is shown in
figure 2.6. The data from the EEG and fNIRS measurement softwares
is sent to two separate buffers, which handle the data flow and events.
The stimulus presentation script sends events to both buffers when the
visual cues are presented to the subject. These events are associated
with the respective sample number in both buffers, and can therefore be
used as a synchronization between the two data streams. The data and
events are further processed and stored by the signal processing scripts
and a backup storage of the raw data is saved by the buffers. The EEG
and fNIRS measurement softwares are written for Windows XP but the
laboratory computer ran Apple OS X, which is better suited for running
multiple Matlab instances at the same time. This was solved by running
the measurement software in a Virtual Windows XP inside OS X, where
the data is transferred to the buffers through the internal network between
the Virtual Machine and the Mac.
Figure 2.6: Diagram showing the software setup used for the
experiment. The data from the data acquisition software (red
square) are sent to each respective buffers (blue squares), these
buffers get events from the same stimulus presentation script
to ensure synchronization. The data is processed exclusively
by one script each. The drivers for the acquisition hardware is
run in a Windows XP virtualbox, the rest is run in Apple OS X.
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2.5 Protocol
The whole experiment can be divided into three blocks:
1. The setup block
2. The trial block
3. The online block
Setup block
The participant is seated in a comfortable chair in front of a monitor in
a soundproof room. The cap with attached optodes and electrodes is
placed on the participant’s scalp, so that the optodes are covering the
motor cortex (C3) on the left hemisphere according to the International 10-
20 system for electrode placement [33]. The signal acquisition softwares
are initiated to get a live feed of the data measurement. The optodes and
electrodes are adjusted until the noise is minimal by moving the hair to the
side under the holes for optodes if needed, and by applying more water
to the electrodes. When a clear signal is visible, a band is fastened around
the participant’s head to ensure that the optodes are kept in place during
the experiment.
Trial block
The subjects is presented with six sequences of six random task trials plus
one "no movement" trial at the start of each sequence, which gives a total
of 36 evenly distributed task trials (6 hand, 6 foot and 6 no movement)
plus 6 additional no movement trials. Each trial consists of a 5 s baseline
period, where the subject is asked to sit as still as possible, a 15 s period
where the subject has to perform the task, and a random silent resting
period between 15 and 25 s to ensure that the signal returns to baseline
before the next trial, see figure 2.7 on the next page.
The running stimulus script will present the visual cues, with instruc-
tions, to the participant according to the randomly selected task. The in-
struction is either:
• “Tap your fingers”, where the participant will perform a tapping
motion with the fingers, but try to not move any other part of the
body.
• "Move your toes", where the subject will "crunch the toes" so that
the movement is isolated to the feet and is not affecting the legs and
upper body.
• "Do not move" , where the participant will keep still.
38
2.5. PROTOCOL
Figure 2.7: Diagram showing one sequence of the experiment
trial block. Each sequence starts with an initial resting period to
ensure a stable baseline, and the first no movement trial (pink)
is recorded in this period. After baseline is established, random
task trials of 15 s each (red) will commence, followed by a semi-
random resting period (grey). The reason for a semi-random
resting period is to eliminate response which can be caused by
expectancy.
• During the resting period the visual instruction is "Rest".
A screen showing the visual instructions of the task is placed in front
of the participant. EEG measurements are subjected to significant noise
as a result of eye movement and eye blinks so to minimize that effect the
subjects are asked to keep their eyes focused on a dot in the middle of the
screen in front of them.
After each sequence the participant is able to take a moment to relax,
have a drink of water, re-position their seat, etc. They are told to signal
when they are ready for the next sequence, this is done so that the
participant can feel more at ease and in control of the situation.
Online block
The online block consists of a small game which the participant can play
until they no longer wish to. The objective of this game is to fill four
circles by tapping the fingers during a recording period. The classifier
trained in the preceding block is applied to the recorded data and will
try to determine the intention of the participant. If the classifier predicts
movement a circle is filled, if the classifier predicts no movement all the
circles are blanked out and the participant must start over. The purpose
of this block is just a proof of concept that online fNIRS is possible with
integration to the Field Trip buffer system. This block was later omitted,
reasons for this is discussed in chapter 4 on page 59.
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2.6 Data analysis procedures
The data from the experiments are preprocessed and analyzed separately
to plot the average brain activity for all subjects during the different
movement tasks, this is done by converting the raw fNIRS and EEG
data into hemodynamic changes and spectral densities respectively. This
is done to show whether the brain signals exhibit patterns which are
expected: blood oxygen level dependent response (BOLD) for fNIRS and
sensorimotor rhythms (SMR) for EEG. This will thereby show that the
basis for calculating the performance of each modality is sound. The
performance is then calculated using a linear logistic regression classifier
and compared, using a Wilcoxon rank sum test to determine significance.
The center of gravity (CoG), i.e. the location where the brain activity
originates, is then calculated by weighing each channel location by the
relative strength of the response for that channel.
All analyses are done post hoc in Matlab, using tools and functions
developed at the Donders Inst., see Appendices F on page 137, in
addition to functions and scripts written by the author of this thesis, see
Appendices E on page 101.
2.6.1 fNIRS data processing and analysis
The raw fNIRS data consists of 16 channels of optical density values which
are converted into relative hemoglobin changes using the modified Beer-
Lambert law. The bad channels are identified and removed based on a
robust variance/mean computation, see Appendix F.3 on page 142. The
beginning and end of the fNIRS data stream is also removed, because
it contains movement artifacts from when the cap is adjusted and taken
off. The remaining data is filtered as a whole with a low pass FFT-filter at
0.35Hz to remove general noise from light absorption due to hair follicles,
skull thickness etc. (>100Hz) and artifacts like the heart pulse (approx.
1Hz). The data is further high pass filtered at 0.01Hz to remove slow drifts.
The data stream is then sliced into trials based on the events registered
during the experiment. The data used for classification is further sliced
into three second segments of the trial ranging from +3 s to 18 s, this is
to give the classifier training more trials and to prevent overfitting. All
further processing is for illustrative purposes, the classifications are based
on the data up until this point. The trials are de-trended by subtracting
the 0-mean and linear trends, see Appendix F.2 on page 139. After this
a 5 second baseline average is subtracted from each channel before the
channels are averaged. The bad trials are removed using the same function
as for identifying the bad channels. The average of all trials for each
condition and each subject is calculated before calculating and plotting the
grand average BOLD response. The average for each subject is normalized
by calculating and dividing by the Euclidean distance of the data vector,
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this is done to account for the variability among subjects. See figure 2.8 for
a flowchart of the fNIRS data analysis.
Figure 2.8: Flowchart showing the analysis pipeline for the
fNIRS data ending in plot (fig. 1.7 on page 18) and performance
(tab. 3.1 on page 51).
2.6.2 EEG data processing and analysis
The event related de-synchronization (ERD) is a change in the power
spectrum of the signal recorded with EEG from the motor cortex, which
occur during movement. The spectral density of the data recorded during
movement will therefore be noticeably different than the spectral density
of the baseline data (no movement). This difference is a measure of how
large the brain activity is for each channel, and is used to plot where the
brain activity is located.
Firstly, the 32 channel EEG data is de-trended and the bad channels are
identified and removed from further analysis using the same functions
as for the fNIRS data analysis. Then a spatial filter is applied to remove
the common average noise among the electrodes. The bad trials are
removed from further analysis by the same procedure as for channels. A
Welch filter is applied to convert the signals to power spectrum densities.
The frequencies of interest are sub-selected and the area under receiver
operating curve (AUC) is calculated. The receiver operating curve is the
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rate of true positives (sensitivity) as a function of the rate of false positives
(fall-out). The AUC is computed by calculating the area under this curve.
The AUC is a measure of discrimination between two data sets (in this
case hand or foot movement vs no movement) and is plotted to show
the discrimination between movement task and no movement for each
electrode. In other words, if the discrimination is high there is a large
response recorded in that area. The data is further used to train a linear
logistic regression classifier, same procedure as for the fNIRS analysis
procedure. The analysis procedure for EEG data is presented as a flow
chart in figure 2.9.
Figure 2.9: Flowchart showing the analysis pipeline of EEG
data ending in plot (fig. 3.4 on page 49, fig 3.2 on page 47) and
performance (tab. 3.1 on page 51).
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2.6.3 Classifier
To assess the performance of the two modalities the data recorded in
the trial block, and the classes associated with it, is fed to a classifier
training algorithm (Appendix F.4 on page 145). This algorithm uses a
linear logistic regression model and tries to relate the data to the known
output, i.e. classes. Because biological data has a high degree of variation
this algorithm uses a 10-fold cross validation, meaning that it separates
the data into 10 subsets and uses 9 to train the classifier which is tested on
the remaining subset. This is done consecutively for all the subsets and
the optimal regularisation strength is then selected. This gives a measure
of performance based on the percentage of true positive classifications the
algorithm achieves during its testing phase, where 0.5 is pure chance and
1.0 is perfect discrimination between classes. The classification analysis
is separated into hand vs no movement and foot vs no movement and
calculated for EEG and fNIRS separately.
2.6.4 Center of Gravity
fNIRS. To calculate the center of gravity (CoG) for fNIRS, each channel
location is weighted by the mean hemodynamic response for that channel.
This is the same procedure used by Koenraadt et al. [45]. The Xi represents
the x y coordinate of each channel, ai represents the mean hemodynamic
response for each channel. The XCoG is calculated for both HbO and
HbR separately. The hemodynamic response for HbR is negative, so ai
is calculated from the absolute value.
XCoG =∑ aiXi/∑ ai (2.1)
EEG. To calculate the CoG for EEG the same principle of weighing
channels by their mean response follows, the difference being that the
event related de-synchronization (ERD) is the measure of response. Each
channel location is weighted by the relative ERD for each channel which
is a measure for the strength of the response. This is done by subtracting
the average power across all frequencies in the no movement condition
for each channel, bi, from the average in the movement condition, ai, and
dividing by bi. This fractional reduction in power during movement is
< 1 for ERD and > 1 for ERS. The positive channels are then weighted by
1− relERD.
relERD = (ai − bi)/bi (2.2)
cW = 1− relERD (2.3)
XCoG = ∑XicWi/∑ cWi f or XERDi > 0 (2.4)
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The participant performs the hand movement task with both hands,
and the response will therefore be located in the motor cortices of both
brain hemispheres and the CoG for EEG will have two locations of origin.
The weight of the left hand response will draw the CoG towards the
center. The fNIRS is only measured on the left hemisphere, however, so
to compare the two the CoG for EEG, hand movement, is calculated using
only the electrodes on the left hemisphere. For the foot movement task the
electrodes from both hemispheres are used, since the foot movement CoG
for EEG is expected to be around the vertex (most central point, Cz in the
10-20 system) and it will only be used to calculate the correlation between
∆CoG and classification rate.
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Results
16 participants signed up for this study, one was excluded due to not
meeting the criteria for participation, and 3 did not show up at the
scheduled time. Experiments were conducted on the remaining 12
subjects (7 female) aged from 22 - 60 (mean 30 ± 10.3SD), at Radboud
University in Nijmegen, the Netherlands. The participants were paid 25
Euro to participate, and they all gave their freely informed consent before
participation as per regulations. No adverse effects were observed during
the experiments.
All the results are produced according to the analysis procedures
described in section 2.6 on page 40. The data behind these results are from
subject 3 to 12, the data from the first two subjects have been excluded due
to hardware issues during the experiment, resulting in only fNIRS data
with no EEG data for comparison. The results are discussed further in
chapter 4 on page 59. The figures presented in this section show patterns
which are expected for both EEG and fNIRS.
3.1 BOLD response
The grand average hemodynamic response for each task, obtained by
averaging over all trials and subjects is presented in fig 3.1 on the
following page. The trial duration, i.e. the duration of stimuli, is from
0 - 15 seconds and is marked with yellow. The grey fields represent one
standard deviation above and below the mean oxygenated (HbO) and de-
oxygenated (HbR) hemoglobin response respectively.
When the trial begins, the consumption of oxygen in the motor cortex
is increased, resulting in a decrease of de-oxygenated hemoglobin and
an increase of oxygenated hemoglobin, as the blood vessels expand to
accommodate the increased demand for oxygen to the cells in the activated
area. The BOLD response takes approx. 7 seconds to reach max and
min level of HbO and HbR respectively, and is expected to maintain
approximately maximum amplitude until stimulus ends. Both hand
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movement and no movement exhibit the patterns which are expected. The
foot movement response, however, returns to baseline approx. 7 seconds
before the stimulus ends. Reasons for this is discussed further in the next
chapter.
Figure 3.1: Total grand average of the BOLD response for the
three movement conditions, hand movement, foot movement
and no movement. The data has been normalized to account
for the variability among subjects. The duration of stimulus is
from 0 - 15 s, marked with yellow. The grey fields represents
one standard deviation above the HbO and below the HbR
mean response respectively. The hand and no movement plots
show the expected patterns in the hemodynamic response. The
foot movement response returns to baseline after the initial rise
approx. 7 seconds earlier than expected.
3.2 Sensorimotor rhythmic response
The area under the receiver operating curve (AUC) is a measure of
discrimination between movement and no movement tasks in the power
spectrum. In other words, an AUC value towards 1.0 means that there
is a large difference in power for a certain frequency. The grand average
AUC plots for each electrode, averaged over all the subjects are presented
in figure 3.2 on the next page and 3.4 on page 49 for hand vs no
movement and foot vs no movement respectively. The event related de-
synchronization (ERD) is a decrease in power in the mu (8 - 12 Hz) and
beta (18 - 30 Hz) bands of the electro-physiological brain signal, which
means that when there is a stronger AUC, there is an ERD: an indicator of
cortical activity in the motor cortex. Grand average spectral densities for
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each electrode are presented in figure 3.3 on the next page and figure 3.5
on page 50, for hand and foot movement response respectively.
As seen in figure 3.2, there is clear activity around C3 and C4, where
the location of hand movement cortical activity is expected to be. The
foot movement response is generally weaker than for hand movement,
possibly because the source is located deeper within the brain. However,
it is largely situated around Cz, which is expected. Note that the response
for hand movement is larger over C4, i.e. the opposite side to where the
fNIRS optodes are located. These plots are showing that the sensorimotor
rhythms exhibit the patterns which are expected for cortical activity of
hand and foot movement
Figure 3.2: Grand average of area under the receiver operating
curve (AUC) for hand movement condition for each electrode.
A high discrimination between classes (towards red) is show-
ing that the cortical activity is localized around C3 and C4, the
areas associated with hand movement. An AUC value of 0.5
means no discernible discrimination, i.e. pure chance. This plot
shows patterns that are expected for hand movement cortical
activity. Note that there is a larger response around C4 on the
right hemisphere which is the opposite side of where the fNIRS
optodes are placed.
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Figure 3.3: Grand average spectral densities for each electrode,
hand movement condition. An ERD is the reduction in power
for the movement condition vs the no movement condition. A
clear decrease in power can be seen around C3 and C4.
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Figure 3.4: Grand average of the area under the ROC curve
for each electrode, foot movement task. A high discrimination
(towards red) for frequencies around 18-30Hz is a typical
indicator of cortical activity. The activity is localized around
Cz. This plot show the patterns which are expected for foot
movement cortical activity.
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Figure 3.5: Grand average spectral densities for each electrode,
foot movement condition. An ERD is the reduction in power
for the movement condition in regards to the no movement
condition. The decrease in power is weaker than for hand
movement, but can be seen in Cz. The source is located deeper
within the brain and might explain why this is so.
50
3.3. CLASSIFICATION RATES
3.3 Classification rates
Calculating the classification rate is based on the ability to discriminate
between the individual movement tasks and the no movement task.
Classification rates for each subject and both modalities and tasks are
presented in table 3.1. Both modalities are able to discriminate between no
movement and movement (hand and foot) with significance. The average
performance of fNIRS and EEG for hand movement task is 0.77 and 0.86
respectively and for the foot movement task the performance is 0.70 and
0.89. Due to the characteristics of the classification rates, this being that
they are bound between 0 and 1 and that they tend to be non-gaussian, a
Wilcoxon rank-sum test was chosen to determine the significance [52] of
differences. Performing the test reveals a significant difference between
EEG and fNIRS in the foot movement task (p = 0.013), but the difference
in hand movement task did not reach significance (p = 0.14).
Subject fNIRS hand fNIRS foot EEG hand EEG foot
S3 0.78 0.68 0.67 0.96
S4 0.82 0.72 0.92 1.00
S5 0.57 0.50 1.00 0.96
S6 0.85 0.73 0.62 0.71
S7 0.80 0.72 1.00 0.66
S8 0.65 0.71 0.83 0.96
S9 0.77 0.51 1.00 0.83
S10 0.94 0.80 0.56 0.91
S11 0.70 0.93 1.00 1.00
S12 0.83 0.74 0.96 0.87
Mean 0.77 0.70 0.86 0.89
SD 0.11 0.12 0.17 0.12
Table 3.1: Classification rates for each subject. Classification
rates are based on training the data with a 10-fold cross
validating linear logistic regression algorithm, as explained
in section 2.6.3 on page 43. The numbers are a measure of
performance, where 1.0 is a perfect discrimination between
classes and 0.5 is pure chance, i.e. the classifier cannot predict
the outcome. The average performance of EEG is significantly
higher than fNIRS when detecting foot movement, but the
difference between average performance when detecting hand
movement did not reach significance.
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(a) Classification rates for each subject, hand movement task.
(b) Classification rates for each subject, foot movement task.
Figure 3.6: Classification rates for each subject, hand and foot
movement task. These diagrams range from 0.45 to 1.0, because
0.5 is, essentially, the lowest possible score and means that
the classifier can only guess the intention of the user. Subject
S5 and S9 had no significant classification rate for fNIRS, foot
movement. Subject S5 scored low for both hand and foot
movement with fNIRS.
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3.4 Task discrimination using fNIRS
To produce evidence on whether a system using fNIRS is able to
discriminate between the center of gravity (CoG) for hand and foot
movement, each channel location is weighed by the mean response for
that channel. The cap is placed on the subject’s head according to the
standards for electrode placement. This ensures that the optodes are
placed in approximately the same location, minimizing the variability
among subjects.
The results are presented in table 3.2, and the average is plotted in
figure 3.7. This plot represents the fNIRS area of coverage, which is an
area of 8 x 4.4 cm centered over C3, as previously explained. The x-
axis is mediolateral direction and the y-axis is anteroposterior. The grey
and black circles represent the transmitters and receivers that are placed
on the scalp, respectively. The diamonds represent hand movement,
and the squares represent foot movement. The foot movement CoGs
are located more lateral than hand movement, although no significant
difference between hand and foot movement was found when performing
a student’s t-test.
Hand HbO Hand HbR Foot HbO Foot HbR
subject X Y X Y X Y X Y
S3 3.68 1.78 3.99 1.84 3.76 1.55 3.88 1.13
S4 5.62 1.96 2.80 2.32 3.94 1.55 4.08 1.64
S5 3.81 1.52 4.12 2.27 4.59 1.42 2.95 2.10
S6 3.90 1.32 4.03 1.62 3.89 1.17 1.57 2.84
S7 5.27 1.55 3.29 2.53 2.99 2.49 4.34 2.05
S8 4.61 1.69 3.82 2.20 4.68 1.76 4.26 2.11
S9 3.63 1.51 2.07 2.40 2.31 2.38 2.09 2.36
S10 5.43 1.97 5.42 1.91 5.55 2.03 5.48 1.88
S11 5.15 1.99 4.39 1.76 4.78 1.93 5.48 2.32
S12 3.43 1.97 3.90 1.99 3.34 1.59 3.13 2.54
Mean 4.45 1.73 3.78 2.08 3.98 1.79 3.73 2.10
SD 0.81 0.23 0.86 0.29 0.91 0.40 1.23 0.45
Table 3.2: Coordinates for the center of gravity for each subject,
fNIRS, hand and foot movement. The numbers are centimeters
from the lower left optode. The center point (C3), is located
at X, Y = [4, 2.2]cm, see figure 3.7 on the next page. No
significant difference between hand and foot movement, for
either oxygenated (HbO) or de-oxygenated (HbR) hemoglobin,
was found.
53
CHAPTER 3. RESULTS
Figure 3.7: Center of gravity for hand and foot movement
measured by fNIRS, diamonds and squares represent hand and
foot movement respectively. Red and blue represents HbO
and HbR respectively. The grey and black circles represent
the location of the transmitters and receivers respectively.
No significant difference between location for hand and foot
movement was found, see table 3.2 on the previous page.
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3.5 Difference in CoG (∆CoG)
The difference in average CoG for the two modalities, hand and foot
movement task, is shown in figure 3.8 and figure 3.9 on the next page.
The CoG for EEG, hand movement task, is calculated using the data from
electrodes located on the left hemisphere only, this is because the subjects
were instructed to move both hands during the trial. Moving both hands
will produce a response on each hemisphere, as seen in figure 3.2 on
page 47, so to compare EEG with fNIRS, which is only recording on the
left hemisphere, the electrodes on the median line and right hemisphere is
removed from the analysis. Foot movement cause only a single CoG for
EEG so in this case both hemispheres are used for analysis.
Figure 3.8: Grand average CoG, hand movement task, for EEG
and fNIRS plotted on the area covering the left hemisphere
motor cortex. The grey and black circles represent fNIRS
transmitters and receivers. The red and blue diamond represent
the CoG for fNIRS, HbO and HbR. The green square represent
the CoG for EEG. This plot show that all CoGs are located
around C3, where hand movement response is expected to be.
The CoGs presented in figure 3.8 is located where they are expected to
be. However, the foot movement CoGs measured with fNIRS, presented in
figure 3.9 on the following page, is located more laterally than expected.
To see if the difference in CoG (∆CoG) affects the performance of fNIRS,
the correlation between ∆CoG and performance for fNIRS is calculated.
Subject S4 was excluded from these analyses due to no relative ERD in the
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EEG i.e. no data for comparing the two modalities.
Figure 3.9: Grand average CoG, foot movement task, for EEG
and fNIRS plotted on the area covering the left hemisphere
motor cortex. The grey and black circles represent fNIRS
transmitters and receivers. The red and blue diamond represent
the CoG for fNIRS, HbO and HbR. The green square represent
the CoG for EEG. The location for foot movement in the motor
cortex is in the central sulcus a couple of centimeters down, and
the CoG for both modalities are therefore expected to be close
to the vertex (Cz). This plot shows that the CoG for EEG is
located approximately where it is expected to be, but the CoGs
for fNIRS is more lateral than expected, i.e. they should be
closer to Cz.
The correlations between the ∆CoG and the fNIRS classification rates,
which is a measure of how reliably the system can detect movement, were
calculated, and the results are presented in figure 3.10 on the next page. No
significant correlation between the ∆CoG and performance was found.
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Figure 3.10: Left: Correlation between ∆CoG and classification
rate for fNIRS, hand movement (r = 0.18, p = 0.65). Right:
Correlation between ∆CoG and classification rate for fNIRS,
foot movement (r = −0.36, p = 0.35). No significant correlation
between ∆CoG and the classification rates were found.
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Chapter 4
Discussion
Observations
During the experiment the results gathered with a post hoc analysis did
not show any intelligible results, and a debugging of the whole system was
necessary. No error in the data recording pipeline was found, but several
small errors in the signal processing procedure were. Additionally, it was
discovered that the instructions given to the participant were somewhat
misinterpreted, and resulted in the participant moving during the initial
resting period where the first no movement trial of each sequence was
recorded. This was corrected by simply removing the first trial of each
sequence for all subjects in the analysis. Because of these errors, the online
block which was planned was not executed for any of the participants.
This block was only meant as a proof of concept for the use of fNIRS
online, and therefore not critical for answering the research questions.
A moderate anti-correlation (r = −0.59, p = 0.09) between classific-
ation rates, i.e. performance, for hand movement for the two modalities
was observed, suggesting that the two modalities might be mutually ex-
clusive in this study. This is presented in figure 4.1.
It was also observed that the subjects with darker hair color had noisier
fNIRS signals than the subjects with blond hair, although this resulted in
more of the channels being removed for the dark hair subjects during the
analysis procedure, the bold response was not affected by this. This is
merely a subjective observation, but might be interesting for future studies
to give more evidence on the robustness of fNIRS.
Primary objective
The primary objective of this study was to determine if using fNIRS yields
a higher performance rate when detecting movement of the hands and feet
than EEG using a 10 fold linear regression classification training on the
measured data. From the results in section 3.3 on page 51 the classification
rates for hand movement, both EEG and fNIRS, are on par with findings
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Figure 4.1: Correlation between classification rates for both
modalities, hand movement task (r = −0.59, p = 0.09),
showing a moderate, yet significant, anti-correlation.
from similar studies (Blokland et al.[28], Fazli et al.[35]). Considering
that the cap was a prototype and that the subjects were not extensively
selected, these classification rates are relatively high. However, comparing
the two modalities to each other reveals that the EEG has a higher
classification rate than fNIRS at detecting both hand and foot movement,
although not statistically significant for hand movement (P = 0.14).
An anti-correlation between performance rates when detecting hand
movement was observed, see figure 4.1, which suggests that the two
modalities are mutually exclusive in this particular setup, i.e. when one
modality performs well the other does not. This further suggests that the
connection between electrode/optode and the scalp can only be optimal
for one of the modalities at a time. Figure 3.2 on page 47 also reveals
that the hand movement response, recorded with EEG, is stronger on the
right hemisphere opposite to where the fNIRS optodes were placed. These
observations suggest that the combined optode/electrode setup used in
this study, can not measure the response reliably simultaneously.
Observation 1. AUC plot showing less response on left hemisphere, see fig 3.2
on page 47.
Possible explanation: EEG does not detect cortical activity as well where
it is combined with fNIRS.
Observation 2. The performance when detecting hand movement for EEG and
fNIRS anti-correlates.
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Possible explanation: The optode/electrode setup makes the system mu-
tually exclusive for EEG and fNIRS.
Conclusion: The combined optode/electrode setup, used in this study, does not
detect movement in the same area reliably.
Secondary objective
The secondary objective was to determine if a system using fNIRS is able
to discriminate between hand and foot movement. As can be seen in
figure 3.1 on page 46, the hemodynamic response to foot movement task
drops to baseline after the initial rise, where the hand movement task
settles at max. amplitude throughout the duration of stimulus. This might
indicate that fNIRS is not in fact measuring the foot movement, but rather
a propagating effect caused by the surge of oxygenated blood through the
cortex as the foot center, which is located deeper in the brain, is activated.
The location of foot movement CoG, as seen in figure 3.7 on page 54,
might also be an indicator of this, since it is located more lateral than
hand movement when it was expected to be more medial, because the
physiological location for foot movement cortical activity is in the central
sulcus (close to the vertex), see figure 1.5 on page 13.
A study on mice conducted by Sheth et al.[53] found that the
hemodynamic response starts to propagate after 2-3s and continues for
several seconds, the cerebral blood volume changes propagate retrograde
into feeding arterioles and the oxygenation changes anterograde into
draining veins. Another study conducted by Chen et al.[54] states that the
propagation of vasodilation is independent of direction of blood flow and
has a decay phase that has a uniform spatial dependence. The propagation
occurs rapidly in directions away from center, and the return to baseline
is first observed in peripheral regions, last at the center of parenchyma
(region of activation). Based on the facts stated in these studies, I will
argue the possibility of one out of two different, probable scenarios,
although further studies are needed to verify this:
1. The foot center is first activated and the hemodynamic response
propagates upwards to the area that fNIRS detects. If this is true
the signal will show up as a response and then return to baseline
sooner than at the center of parenchyma. The center and peripheral
regions reach peak response at approximately the same time, but the
return to baseline starts first in the peripheral regions, see diagram
in figure 4.2 on the next page.
2. The measured hemodynamic response is actually a measurement
of residual movement in the upper body as the subject starts the
task. The diagram in 4.3 on page 63 represents this scenario. When
the subject settles to a stable movement rhythm the upper body
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parenchymas will stop being active and the measured response will
return to baseline earlier than expected. If this is true, the fNIRS
channels are not able to target the foot movement parenchyma in
this setup.
Figure 4.2: Diagram showing a possible propagation of vas-
odilation through the tissue during foot movement. The foot
movement parenchyma (response origin) is located in the cent-
ral sulcus. As stimulus progresses, the hemodynamic response
propagates outwards and may be detected by the fNIRS chan-
nel targeting the hand movement parenchyma. When the stim-
ulus ends the vasodialtion will first subside at the farther region
from the parenchyma which might explain the short response
for foot movement in figure 3.1 on page 46.
EEG has a significantly higher performance rate than fNIRS at
detecting foot movement, which infers that EEG is more reliable. If
scenario 1 is true, i.e. fNIRS is in fact targeting the correct area, then
I can conclude that EEG has a higher performance rate than fNIRS at
detecting foot movement. If scenario 2 is true, i.e. the fNIRS optodes
are not targeting the foot movement area but rather measuring residual
upper body movement, then this will further argue the importance of the
optode setup, meaning more optodes are needed to ensure proper cortical
coverage.
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(a) Hemodynamic response propagation from 0 - 7 s.
(b) Hemodynamic response propagation from 8 - 15 s.
Figure 4.3: Diagram showing a possible propagation of vas-
odilation during foot movement stimulation. At the start of
the stimulus cue there might be residual movement in the up-
per body and arms. Once the subject stabilizes, this residual
movement may be reduced, meaning that the response which is
measured is not produced by the foot movement parenchyma,
but rather residual upper body movement, and therefore will
subside earlier than expected.
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Observation 1. The fNIRS CoG for foot movement was measured more lateral
than the CoG for hand movement.
Possible expl.: The fNIRS might be measuring something else than foot
movement.
Observation 2: The hemodynamic response propagates through tissue.
Possible expl. A: The measurement is of actual foot movement, see fig 4.2
on page 62.
Possible expl. B: The measurement is of residual upper body movement,
see fig 4.3 on the preceding page.
Observation 3. EEG has significantly higher performance rate at detecting foot
movement than fNIRS.
Conclusion: If explanation A is true, the system is targeting the correct area
and EEG has a significantly higher performance rate. If explanation B is
true, the optode setup is not targeting the correct area.
Tertiary objective
The third objective, as stated in section 1.5 on page 23, was to determine if
the difference in location of center of gravity (CoG) for fNIRS and EEG
correlates with the classification rate for fNIRS. As seen in figure 3.10
on page 57, no significant correlation between the ∆CoG and fNIRS
classification rate was found for either movement task. This means the
CoG for EEG falls within the fNIRS area of coverage. If the true CoG
would be outside the area of fNIRS coverage the classification rate for
fNIRS would be 0.5 (lowest possible) for that measurement, and the
correlation would show an “all or nothing” characteristic, in other words,
some kind of hemodynamic response is measured within the fNIRS area
of coverage. Whether this response is true to the type of movement task,
can not be determined by this analysis.
Observation 1. No significant correlation between difference in CoG and fNIRS
performance.
Conclusion: Some kind of hemodynamic response is measured within the fNIRS
area of coverage.
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Sources of error
The cap that was used was a prototype which was modified with
styrofoam and glue. This, of course, was not optimal and might have
led to the optodes and electrodes not being in as close contact with the
scalp as they require, suggesting one reason for the lack of significant
answers. Another possible reasons for this lack of significance might also
be misinterpretations of the instructions given to the participants. If the
participant were to move a few seconds before a new trial, the baseline
recording would be contaminated with movement response because the
hemodynamic response is quite slow. Although the participants were
monitored during the experiments, and corrected if this was observed, a
small portion of the recorded trials were probably affected by movement
contamination. The classification rates, which are calculated from un-
baselined data, is not affected by this, but it may, however, have led to
more of the trials being removed later in the analysis procedure, and
thereby increasing the variance. For future fNIRS studies I will suggest
that this must be taken in close consideration, and that measures must be
taken to ensure a contaminate free baseline. This can be done by increasing
the baseline period, and giving more strict instructions to the participant.
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Chapter 5
Summary of findings
The main aim of this study is to determine whether or not fNIRS may be
considered a feasible alternative to EEG in an intraoperative awareness
monitoring system, based on the modalities’ performance at detecting
hand and foot movement, in addition to meeting the criteria for clinical
feasibility: a minimal generic electrode/optode montage that works for
all patients, and takes a minimal amount of time to set up; a false positive
rate not exceeding one per two hours operating time, and a time to detect
awareness not exceeding 2.5 min.
Regarding the false positive rate and time to detection, the online
block that was scheduled was not executed due to issues with the signal
processing during the experiments. I deemed it necessary to perform
a debugging of the system to ensure that the recorded data was not
compromised, and because I was pressed for time the online block was
omitted. This block was meant more as a proof of concept, and answering
the proposed hypotheses had a higher priority.
BCI systems that combine fNIRS and EEG have shown promise when
it comes to increased performance [28, 35], and it might also be a method
to use in order to solve the problem of BCI illiteracy. However, in an
application where setup time and ease of use is essential, such as an
intraoperative awareness monitor, this increased performance has to be
substantial in order to outweigh the disadvantage of a prolonged or too
complex setup.
The first objective was to determine which modality had the best
performance rate at detecting hand and foot movement. Although
no definite conclusions regarding hand movement can be drawn, the
observations made in this objective indicates that the combined EEG-
fNIRS setup cannot reliably measure the responses simultaneously. This,
in turn, means that the fNIRS optode placement cannot rely on the 10-20
framework for electrode placement. One possible action to ensure that
the optode placement targets the correct area is to perform a testing block
before the actual measurement, and adjust the optode placement to where
the response is strongest. This would mean an increased setup time which
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is an argument against the use of fNIRS in an intraoperative awareness
monitor where setup time is essential for its feasibility.
For the second objective, which was to determine if fNIRS has the
ability to discriminate between hand and foot movement, the observations
made indicates that the optodes may not target the correct area. If the
optodes are in fact targeting the correct area, then I can conclude that EEG
has a significantly higher performance rate than fNIRS at detecting foot
movement. However, if the optodes are not targeting the correct area,
a larger number of optodes are needed to ensure that the measurement
is correct. This will increase both the setup time and complexity if
this paradigm were to be implemented in an intraoperative awareness
monitor.
In any case, the setup is affected, either by prolonging the time it takes
to ensure a reliable signal, or by adding to the complexity of the elec-
trode/optode montage, see deduction tree in figure 5.1 on the next page. I
will argue, based on these observations, that functional near-infrared spec-
troscopy (fNIRS) is not a feasible alternative to electroencephalography
(EEG) as measurement technology in an intraoperative awareness monit-
oring system, although further research is needed to verify this argument.
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declare under our sole responsibility that the product: Oxymon MKIII 
to which this declaration relates is in conformity with the following harmonised standards: 
 
 
Directives:    LVD 73/23/EEC 
     EMC 89/336/EEC 
 
Product Safety Standard:  EN61010-1:1993/A2:1995 
 
Laser Safety Standard:   EN60825-1:1994 
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The Oxymon MKIII is to be used as investigational tool only. 
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OXYMON Mk III 
Optical Imaging made easy and affordable 
Introduction 
Applications 
Principle 
All cells in all organs of the body have a constant but 
variable need for oxygen. However the body stores for 
oxygen are minimal. So a constant and adequate supply 
of oxygen to the tissues through the circulation is 
essential. In critical situations therefore monitoring a 
subject’s local tissue oxygenation can be of life-saving 
value. This information can be obtained with the 
Oxymon which utilizes the technique of near infrared 
spectroscopy.  
Main applications are found while monitoring brain and/
or muscle tissue: 
 
   > Researching patients in the operating theatre or in 
intensive care units where the oxygen supply to the 
brain might become critical. 
   >   Neonatal research. 
   >   Researching  a hampered blood supply to the limbs, 
e.g. as seen in peripheral vascular disease. 
   >   Monitoring of regional muscle oxygenation in sports 
medicine or during rehabilitation training. 
   > Measuring regional flow, volume and saturation. 
   >   Functional brain monitoring, e.g. measuring the 
 response of brain oxygenation to a sensory 
 stimulus.  
   >   Fast optical signal. 
[O2Hb]
[HHb]
Example of a functional NIRS tracing using a 12 
channel setup. The optodes are placed over the 
left motor cortex, while the subject performs a 
finger tapping task with his right hand during 20 
seconds, starting at t = 0 s. An increase in blood 
flow is observed over the motor cortex. 
Near infrared spectroscopy (NIRS), the technique on 
which the Oxymon is based, relies mainly on two 
characteristics of human tissue. Firstly, the relative 
transparency of tissue for light in the NIR range, and 
secondly to the oxygenation dependent absorbance of 
hemoglobin. Using the Oxymon, being based on this 
principle, it becomes possible to monitor your subject: 
 
   > Non-invasively. 
   >   Easily transportable, bedside measurements. 
   >   With continuous recording and feedback. 
   >   Without the need of a special infrastructure. 
   >   Without specially trained personnel. 
   >   Affordable and no disposables needed.  
Example of measurement on muscle, where an 
exercise period (A) is followed by an occlusion 
(B-C) from which the local oxygen consumption 
(mVO2) is determined from the gradient of the 
oxyhemoglobin (O2Hb) signal. 
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Company Information 
 
ARTINIS MEDICAL SYSTEMS BV 
Einsteinweg 17 
6662 PW Elst 
The Netherlands 
 
Tel:  +31 481 350980 
Fax: +31 481 350269 
Mail: askforinfo@artinis.com 
 
© 2011 Artinis Medical Systems B.V. All rights reserved                Rev 1104 
Although we believe that the specifications will not change drastically we have the right to change them without further notice. 
All other trademarks or registered trademarks are the property of their respective owners. 
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Simultaneous NIRS and trans cranial 
Doppler registration of a patient during 
an elective cardiac arrest. Optodes 
were placed on the frontal side of the 
head, with a distance of 5.5 cm. 
The Oxymon is a scientifically sound and user friendly instrument. 
The Oxymon is designed as a plug-and-play instrument. This means 
that you can start with one or two channels, and gradually extend 
the number of channels according to your needs. Data collected with 
the superior analysis software, Oxysoft, included with the Oxymon 
are stored on a separate PC, easily accessible for analysis, backup 
and export. Important are the options for customized hardware and 
software, like NMR compatible probes and fast sampling. Further-
more we can offer superior user support. 
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This is an unfiltered tracing of the oxy-
genation changes in the left visual cor-
tex of one subject, while  watching 13 
blocks of a flickering checkerboard on a 
computer screen (see inlet in right up-
per corner). Each block lasts 20 se-
conds.  
Multi Channel Oxymon Mk III system 
Being a small 
flexible company 
with more than 16 
years of experi-
ence in near infra-
red spectroscopy 
we are aware of 
the special needs 
of scientists. Cus-
tom made addi-
tions to the Oxy-
mon, or support 
with setting up 
your research can 
all be arranged. 
Technology  Continuous wave near infrared spectroscopy using 
   modified Lambert-Beer Law 
Measures  Changes in oxy– and deoxyhemoglobin and optionally
   regional tissue saturation index (TSI) using spatially 
   resolved spectroscopy 
Operating system Windows XP, Vista or 7, with at least USB 1.1 
Channels  Between 1 and 96, depending on configuration and 
   splitting of fibers. Maximum configuration is 2 x 4 
   cabinets with 8 transmitter/8 receiver. Minimum is
   one cabinet with one transmitter/one receiver 
Light source Temperature stabilized pulsed laser sources  
   (Class I according to IEC- 60825-1, safety of lasers) 
Wavelengths Standard nominal 765 and 855 nm, others possible 
Detector(s)  Temperature stabilized and cooled avalanche photo 
   diode with ambient light protection 
Sampling time From 0.1 Hz to 50 Hz (up to 250 Hz optional) 
Noise   ~0.001 standard deviation in optical density at a total 
   of ~6 optical densities at 10Hz measurement frequency  
Storage  Real-time, unlimited data storage 
External inputs Optional are 8 additional analog data inputs at     
   50 Hz (up to 250 Hz optional), +/- 4 Volt 
Optode fibers Standard 3 meter, lengths up to 10 meter available 
Optode holders Standard with multiple distances for muscle or  
   head, multi-channel generally customer specific 
Optode distance Depending on application. Frontal head with brain 
   device up to 6 cm possible with arterial pulsation  
   still visible. For fNIRS 3 - 4 cm is recommended. 
Upgrades  The instrument can easily be upgraded  
Power  Auto sensing 110-240V, approx. 40 Watt 
Dimensions  Weight 7 to 8 kg, WxDxH: 37x30x9 cm 
Environment Operating temp. ~10-27 ºC, both source and  
   detector temperature stabilized, altitude 0-5750 m 
Interference With NMR compatible fibers the instrument can be 
   used inside the MRI. EEG/ECG does not interfere 
   the optical signal 
Technical specifications 
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Appendix C
WMA Declaration of Helsinki -
Ethical Principles for Medical
Research Involving Human
Subjects
C.1 INTRODUCTION
1. The World Medical Association (WMA) has developed the Declara-
tion of Helsinki as a statement of ethical principles for medical re-
search involving human subjects, including research on identifiable
human material and data. The Declaration is intended to be read as
a whole and each of its constituent paragraphs should not be applied
without consideration of all other relevant paragraphs.
2. Although the Declaration is addressed primarily to physicians, the
WMA encourages other participants in medical research involving
human subjects to adopt these principles.
3. It is the duty of the physician to promote and safeguard the health
of patients, including those who are involved in medical research.
The physician’s knowledge and conscience are dedicated to the
fulfilment of this duty.
4. The Declaration of Geneva of the WMA binds the physician with the
words, “The health of my patient will be my first consideration”, and
the International Code of Medical Ethics declares that, “A physician
shall act in the patient’s best interest when providing medical care.”
5. Medical progress is based on research that ultimately must include
studies involving human subjects. Populations that are under-
represented in medical research should be provided appropriate
access to participation in research.
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6. In medical research involving human subjects, the well-being of
the individual research subject must take precedence over all other
interests.
7. The primary purpose of medical research involving human subjects
is to understand the causes, development and effects of diseases
and improve preventive, diagnostic and therapeutic interventions
(methods, procedures and treatments). Even the best current
interventions must be evaluated continually through research for
their safety, effectiveness, efficiency, accessibility and quality.
8. In medical practice and in medical research, most interventions
involve risks and burdens.
9. Medical research is subject to ethical standards that promote respect
for all human subjects and protect their health and rights. Some
research populations are particularly vulnerable and need special
protection. These include those who cannot give or refuse consent
for themselves and those who may be vulnerable to coercion or
undue influence.
10. Physicians should consider the ethical, legal and regulatory norms
and standards for research involving human subjects in their own
countries as well as applicable international norms and standards.
No national or international ethical, legal or regulatory requirement
should reduce or eliminate any of the protections for research
subjects set forth in this Declaration.
C.2 PRINCIPLES FOR ALL MEDICAL RE-
SEARCH
11. It is the duty of physicians who participate in medical research to
protect the life, health, dignity, integrity, right to self-determination,
privacy, and confidentiality of personal information of research
subjects.
12. Medical research involving human subjects must conform to gen-
erally accepted scientific principles, be based on a thorough know-
ledge of the scientific literature, other relevant sources of informa-
tion, and adequate laboratory and, as appropriate, animal experi-
mentation. The welfare of animals used for research must be respec-
ted.
13. Appropriate caution must be exercised in the conduct of medical
research that may harm the environment.
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14. The design and performance of each research study involving hu-
man subjects must be clearly described in a research protocol. The
protocol should contain a statement of the ethical considerations in-
volved and should indicate how the principles in this Declaration
have been addressed. The protocol should include information re-
garding funding, sponsors, institutional affiliations, other potential
conflicts of interest, incentives for subjects and provisions for treat-
ing and/or compensating subjects who are harmed as a consequence
of participation in the research study. The protocol should describe
arrangements for post-study access by study subjects to interven-
tions identified as beneficial in the study or access to other appropri-
ate care or benefits.
15. The research protocol must be submitted for consideration, com-
ment, guidance and approval to a research ethics committee before
the study begins. This committee must be independent of the re-
searcher, the sponsor and any other undue influence. It must take
into consideration the laws and regulations of the country or coun-
tries in which the research is to be performed as well as applicable
international norms and standards but these must not be allowed
to reduce or eliminate any of the protections for research subjects
set forth in this Declaration. The committee must have the right to
monitor ongoing studies. The researcher must provide monitoring
information to the committee, especially information about any seri-
ous adverse events. No change to the protocol may be made without
consideration and approval by the committee.
16. Medical research involving human subjects must be conducted only
by individuals with the appropriate scientific training and qualifica-
tions. Research on patients or healthy volunteers requires the super-
vision of a competent and appropriately qualified physician or other
health care professional. The responsibility for the protection of re-
search subjects must always rest with the physician or other health
care professional and never the research subjects, even though they
have given consent.
17. Medical research involving a disadvantaged or vulnerable popula-
tion or community is only justified if the research is responsive to
the health needs and priorities of this population or community and
if there is a reasonable likelihood that this population or community
stands to benefit from the results of the research.
18. Every medical research study involving human subjects must be pre-
ceded by careful assessment of predictable risks and burdens to the
individuals and communities involved in the research in compar-
ison with foreseeable benefits to them and to other individuals or
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communities affected by the condition under investigation.
19. Every clinical trial must be registered in a publicly accessible
database before recruitment of the first subject.
20. Physicians may not participate in a research study involving human
subjects unless they are confident that the risks involved have been
adequately assessed and can be satisfactorily managed. Physicians
must immediately stop a study when the risks are found to outweigh
the potential benefits or when there is conclusive proof of positive
and beneficial results.
21. Medical research involving human subjects may only be conducted
if the importance of the objective outweighs the inherent risks and
burdens to the research subjects.
22. Participation by competent individuals as subjects in medical re-
search must be voluntary. Although it may be appropriate to con-
sult family members or community leaders, no competent individual
may be enrolled in a research study unless he or she freely agrees.
23. Every precaution must be taken to protect the privacy of research
subjects and the confidentiality of their personal information and to
minimize the impact of the study on their physical, mental and social
integrity.
24. In medical research involving competent human subjects, each
potential subject must be adequately informed of the aims, methods,
sources of funding, any possible conflicts of interest, institutional
affiliations of the researcher, the anticipated benefits and potential
risks of the study and the discomfort it may entail, and any
other relevant aspects of the study. The potential subject must
be informed of the right to refuse to participate in the study or
to withdraw consent to participate at any time without reprisal.
Special attention should be given to the specific information needs
of individual potential subjects as well as to the methods used to
deliver the information. After ensuring that the potential subject has
understood the information, the physician or another appropriately
qualified individual must then seek the potential subject’s freely-
given informed consent, preferably in writing. If the consent cannot
be expressed in writing, the non-written consent must be formally
documented and witnessed.
25. For medical research using identifiable human material or data,
physicians must normally seek consent for the collection, analysis,
storage and/or reuse. There may be situations where consent would
be impossible or impractical to obtain for such research or would
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pose a threat to the validity of the research. In such situations the
research may be done only after consideration and approval of a
research ethics committee.
26. When seeking informed consent for participation in a research study
the physician should be particularly cautious if the potential subject
is in a dependent relationship with the physician or may consent
under duress. In such situations the informed consent should be
sought by an appropriately qualified individual who is completely
independent of this relationship.
27. For a potential research subject who is incompetent, the physician
must seek informed consent from the legally authorized representat-
ive. These individuals must not be included in a research study that
has no likelihood of benefit for them unless it is intended to promote
the health of the population represented by the potential subject, the
research cannot instead be performed with competent persons, and
the research entails only minimal risk and minimal burden.
28. When a potential research subject who is deemed incompetent is
able to give assent to decisions about participation in research, the
physician must seek that assent in addition to the consent of the
legally authorized representative. The potential subject’s dissent
should be respected.
29. Research involving subjects who are physically or mentally incap-
able of giving consent, for example, unconscious patients, may be
done only if the physical or mental condition that prevents giving
informed consent is a necessary characteristic of the research pop-
ulation. In such circumstances the physician should seek informed
consent from the legally authorized representative. If no such repres-
entative is available and if the research cannot be delayed, the study
may proceed without informed consent provided that the specific
reasons for involving subjects with a condition that renders them
unable to give informed consent have been stated in the research
protocol and the study has been approved by a research ethics com-
mittee. Consent to remain in the research should be obtained as soon
as possible from the subject or a legally authorized representative.
30. Authors, editors and publishers all have ethical obligations with
regard to the publication of the results of research. Authors have
a duty to make publicly available the results of their research
on human subjects and are accountable for the completeness and
accuracy of their reports. They should adhere to accepted guidelines
for ethical reporting. Negative and inconclusive as well as positive
results should be published or otherwise made publicly available.
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Sources of funding, institutional affiliations and conflicts of interest
should be declared in the publication. Reports of research not in
accordance with the principles of this Declaration should not be
accepted for publication.
C.3 ADDITIONAL PRINCIPLES FOR MED-
ICAL RESEARCH COMBINED WITH MED-
ICAL CARE
31. The physician may combine medical research with medical care only
to the extent that the research is justified by its potential preventive,
diagnostic or therapeutic value and if the physician has good reason
to believe that participation in the research study will not adversely
affect the health of the patients who serve as research subjects.
32. The benefits, risks, burdens and effectiveness of a new intervention
must be tested against those of the best current proven intervention,
except in the following circumstances:
The use of placebo, or no treatment, is acceptable in studies where
no current proven intervention exists; or
Where for compelling and scientifically sound methodological reas-
ons the use of placebo is necessary to determine the efficacy or safety
of an intervention and the patients who receive placebo or no treat-
ment will not be subject to any risk of serious or irreversible harm.
Extreme care must be taken to avoid abuse of this option.
33. At the conclusion of the study, patients entered into the study are
entitled to be informed about the outcome of the study and to share
any benefits that result from it, for example, access to interventions
identified as beneficial in the study or to other appropriate care or
benefits.
34. The physician must fully inform the patient which aspects of the care
are related to the research. The refusal of a patient to participate in
a study or the patient’s decision to withdraw from the study must
never interfere with the patient-physician relationship.
35. In the treatment of a patient, where proven interventions do
not exist or have been ineffective, the physician, after seeking
expert advice, with informed consent from the patient or a legally
authorized representative, may use an unproven intervention if
in the physician’s judgement it offers hope of saving life, re-
establishing health or alleviating suffering. Where possible, this
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intervention should be made the object of research, designed to
evaluate its safety and efficacy. In all cases, new information should
be recorded and, where appropriate, made publicly available.
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November 2013, version 1.6
Donders Centre for Cognition 
STUDY-SPECIFIC INFORMED CONSENT FORM 
For participation in:* 
Behavioural EEG Sled Robot 
*tick the applicable box(es) 
To be filled out by the PARTICIPANT prior to the start of the experiment: 
I confirm that: 
- I was satisfactorily informed about the study both verbally and in writing, by means of the general 
information brochure and additional study specific information brochure(s) (versions 1.6, 
November 2013), as well as about the study itself by the researcher concerned. 
- I have had the opportunity to put forward questions regarding the study and that these questions 
have been answered satisfactorily 
- I have carefully considered my participation in the experiment.  
- I participate of my own free will. 
 I agree that: 
- My data will be acquired and stored for scientific purposes as mentioned in the general 
information brochure. 
- My experimental and coded data will be shared with others for strict scientific reasons 
- I will be informed by a designated expert about any information which is of clinical relevance to 
me
I understand that: 
- I have the right to withdraw from the experiment at any time without having to give a reason. 
- My privacy is protected according to Dutch law. 
- My consent will be sought every time I participate in a new experiment. 
-------------------------------------------------------------------------------------------------------------------------------------------- 
I give my consent to take part in this experiment:
Name:………………………………………. Date of birth:……………………………....... (dd/mm/yy) 
Signature:............................................................. Date and place:…………………………………………….... 
-------------------------------------------------------------------------------------------------------------------------------------------- 
To be filled out by the RESEARCHER prior to the start of the experiment:
The undersigned declares that the person named above has been informed both in writing and in person 
about the experiment. He /she guarantees subjects’ privacy protection according to Dutch law.  
Name:……………………………………………….. PI group:……………………………………………………… 
Name experiment:…………………………………………………………………………………………………….. 
Signature:................................................ ……….. Date and place:……………………………………………… 
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Donders Centre for Cognition 
SCREENING FORM *
Version 1.6 
To be filled out by the PARTICIPANT prior to the start of the experiment 
Please answer the following questions first Yes No 
- Do you suffer from a neurological or psychiatric disease?   
-
Do you take psychoactive medication/substances such as antidepressants, 
antiepileptics,antipsychotics or hard drugs? 
- Are you pregnant or do you think you are?   
- Do you suffer from claustrophobia?   
- Are you younger than 18 years?   
If you answered “Yes” to one of the above questions, you may not be able to participate in the 
experiment.
* This form is only to be used for research with people of 18 years or older, who are of sound mind and 
judgement. The person involved has to give his or her consent personally. 
           P.T.O
Name: 
Date of birth: 
Signature:        Date: 
E
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November 2013, version 1.6 
SCREENING FORM 
Version 1.6 
To be filled out completely by the RESEARCHER after the experiment
Name :     PI group : 
Experiment name:  
--------------------------------------------------------------------------------------------------------------------------- 
Reported incidental findings:
Incidental findings       YES/ NO 
           
If YES, please describe:  
Reported adverse events:
Adverse Events        YES/ NO 
           
If YES, please describe:  
Participation in science experiment 
 
“fNIRS as an alternative to EEG in detection of intra-operative awareness” 
 
Fact sheet 
What the study entails 
A cap with several sensors imbedded will be placed on your head, these sensors will                             
measure the oxygen consumption and electrical signals in parts of your brain as the                           
experiment goes on. You will be asked to sit in a chair and follow instruction that will be given                                     
on a monitor in front of you. After each block and sequence you will get a short break to                                     
adjust your position, drink water, etc. The whole experiment consists of three parts and is                             
detailed below. 
 
Part one, cap fitting 
● The first part is to set up the experiment and ensure that the signals are as strong and                                   
clear as possible.  
● This may take up to 30 minutes. 
 
Part two, movement experiment 
● This part is a movement based experiment where your task is to either tap your                             
fingers, tap your feet or sit relaxed and do nothing during a cue on the screen.  
● This part consists of six sequences of seven trials each, after each sequence you will                             
be given time to get ready for the next, have a drink of water, etc. 
● This part will take about 40 minutes 
 
Part three, online feedback 
● After the experiment there is a online feedback part where you get to control a simple                               
computer game. The mission in this game is tap your fingers or feet during a cue and                                 
light up four circles in a row.  
 
 
Possible advantages and disadvantages 
The advantage for you is to partake in new science that may prevent patients from being                               
awake and paralyzed during surgery, and thereby help to prevent possible psychological                       
harm to people. There is no expected risk in participating, the equipment that is used is safe                                 
for use on human subjects and the experiment does not entail any discomfort. The collected                             
data will be saved to a safe location and will be anonymized so that it can not be traced back                                       
to you and thereby not pose any risk to your integrity. 
 
What happens to the collected data and information? 
The data and information about you will only be used as described in this fact sheet. All data                                   
and information will be processed without the use of your name, personal number or other                             
identifiable information. 
 
Voluntary participation 
Your participation is completely voluntary. You may at any time, and without any obligation to                             
give a reason, withdraw from the experiment. Withdrawal from the experiment will have no                           
consequence for you. If you wish to partake you must give your informed consent by signing                               
the agreement form on the next page. If you have signed this form and later wish to withdraw                                   
your consent, you may do so without any consequence. If you have any questions or wish to                                 
withdraw contact Magnus Reinsfelt Krogh at mlkrogh (at) student.matnat.uio.no 
 
Criteria for participation 
The participant: 
● has to be between 18 and 60 years of age. 
● has to have normal health, hearing and vision. Corrected vision is permitted. 
● has to be willing to perform the tasks mentioned above. 
● has to be willing to give his/her informed consent. 
● can not have or have had neurological damage or disease that may propose a risk to                               
the result or to the participant. 
 
Information about the results of this study 
You as a participant have the right to get information about the results and outcome of this                                 
study. Since this study is part of a master thesis the results will be made publicly available                                 
when the thesis is graded. Barring any unforeseen incidents that may delay this thesis it will                               
be made available at duo.uio.no fall 2014. 
 
 
 
 
Appendix E
MATLAB scripts and functions
written by the author
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oxy2ft.m
function []=buffer_nirs(host,port,varargin);
% feed data from Artinis Oxymon to fieldtrip buffer
% Magnus Krogh
% based on signal proxy script developed at Donders Inst. 
%
% []=buffer_nirs(host,port,varargin);
% 
% Inputs:
%  host - [str] hostname on which the buffer server is running (localhost)
%  port - [int] port number on which to contact the server     (1972)
% Options:
%  fsample - [int] data sample rate                            (250)
%  nCh     - [int] number of channels (24)
%  blockSize- [int] number of samples to send at a time to buffer (1)
%  Cnames   - {str} cell array of strings with the channel names in ([])
%               if empty, channel names are 'rand01', 'rand02', etc
%  stimEventRate - [int] rate in samples at which stimulated 'stimulus'  (100)
%                   events are generated 
%  queueEventRate - [int] rate (in samples) at which simulated 'queue'   (500)
%                   events are generated
%  keyboardEvents - [bool] do we listen for keyboard events and generate (1)
%                   'keyboard' events from them?
%  verb           - [int] verbosity level.  If <0 then rate in samples to print 
status info (0)
if ( nargin<2 || isempty(port) ) port=1972; end;
if ( nargin<1 || isempty(host) ) host='localhost'; end;
mdir=fileparts(mfilename('fullpath'));
addpath(fullfile(mdir,'buffer'));
opts=struct('fsample',250,'nCh',24,'blockSize',1,'Cnames',[],'stimEventRate',0,
'queueEventRate',0,'keyboardEvents',false,'verb',0);
opts=parseOpts(opts,varargin);
if ( isempty(opts.Cnames) )
opts.Cnames={'AD1' 'AD2' 'AD3' 'AD4' 'AD5' 'AD6' 'AD7' 'AD8' 'OD1' 'OD2' 'OD3'
'OD4' 'OD5' 'OD6' 'OD7' 'OD8' 'OD9' 'OD10' 'OD11' 'OD12' 'OD13' 'OD14' 'OD15'
'OD16'};
for i=numel(opts.Cnames)+1:opts.nCh; opts.Cnames{i}=sprintf('rand%02d',i); end;
end
% N.B. from ft_fuffer/src/message.h: double -> ft type ID 10
hdr=struct('fsample',opts.fsample,'channel_names',{opts.Cnames},'nchans',opts.nCh,
'nsamples',0,'nsamplespre',0,'ntrials',1,'nevents',0,'data_type',10);
buffer('put_hdr',hdr,host,port);
dat=struct('nchans',hdr.nchans,'nsamples',opts.blockSize,'data_type',hdr.data_type,
'buf',[]);
simevt=struct('type','stimulus','value',0,'sample',[],'offset',0,'duration',0);
keyevt=struct('type','keyboard','value',0,'sample',[],'offset',0,'duration',0);
fsample =opts.fsample;
blockSize=opts.blockSize;
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nsamp=0; nblk=0; nevents=0;
tic;stopwatch=toc;
% key listener
if ( opts.keyboardEvents )
figure(1);set(gcf,'name','Press key here to generate events','menubar','none',
'toolbar','none');
set(gcf,'keypressfcn',@keyListener);
end
%open tmp file
[filen,path]=uigetfile('*.oxy3.tmp','Select .oxy3.tmp file');
fid=fopen(fullfile(path,filen),'r+');
clc;
fread(fid,4); %get rid of header
while( true );
nblk=nblk+1;
nsamp=nsamp+blockSize;
loc=ftell(fid); %get current byte location
fseek(fid,0,1); %move to end of file
eof=ftell(fid); %save end location
fseek(fid,loc,-1); %move back to current location
if((eof-loc)>52)
%feed one line to buffer
OD=fread(fid,16,'int16'); %this is the actual OD values
AD=fread(fid,8,'int16'); %this is the actual AD values
onS=fread(fid,4); %sample information and events
dat.buf(1:numel(AD),:)=(-AD/8000)+4.096; %adjust data, scaling factors and 
offset has been calculated
dat.buf(numel(AD)+1:numel(AD)+numel(OD))=(OD/4000);
buffer('put_dat',dat,host,port);
disp(dat.buf(9:14)'); %just to show that it is running
else
pause(.002);
end
if ( opts.verb~=0 )
if ( opts.verb>0 || (opts.verb<0 && mod(nblk,ceil(-opts.verb/blockSize))==0) )
fprintf('%d %d %d %f (blk,samp,event,sec)\r',nblk,nsamp,nevents,toc-stopwatch
);
end
end
if ( opts.stimEventRate>0 && mod(nblk,ceil(opts.stimEventRate/blockSize))==0 )
% insert simulated events also
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nevents=nevents+1;
simevt.value=ceil(rand(1)*2);simevt.sample=nsamp;
buffer('put_evt',simevt,host,port);
end
if ( opts.queueEventRate>0 && mod(nblk,ceil(opts.queueEventRate/blockSize))==0 )
% insert simulated events also
nevents=nevents+1;
simevt.value=sprintf('queue.%d',ceil(rand(1)*2));
simevt.sample=nsamp;
buffer('put_evt',simevt,host,port);
end
if ( opts.keyboardEvents )
h=get(gcf,'userData');
if ( ~isempty(h) )
keyevt.value=h; set(gcf,'userData',[]); keyevt.sample=nsamp;
buffer('put_evt',keyevt,host,port);
fprintf('\nkey=%s\n',h);
end
end
end
return;
function []=keyListener(src,ev)
set(src,'userData',ev.Character);
%-------------
function testCase();
% start buffer server
buffer('tcpserver',struct(),'localhost',1972);
buffer_signalproxy('localhost',1972);
% now try reading data from it...
hdr=buffer('get_hdr',[],'localhost');
dat=buffer('get_dat',[],'localhost');
% generate data without making any events
buffer_signalproxy([],[],'stimEventRate',0,'queueEventRate',0,'verb',-100)
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mkAnalysisControl.m
%% Control script for signal processing of EEG and NIRS data
%  Magnus L. R. Krogh
%
%% INITIALIZE PATHS %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
if ( exist('initPaths','file') )
initPaths;
else
run ~/buffer_bci/utilities/initPaths;
end
%%
Rx1=1; Rx2=2; Tx1=[1,2]; Tx2=[3,4]; Tx3=[5,6]; Tx4=[7,8];
%% OPTIONS %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
names={'all'}; % names of subjects in the raw data file
types={ 'offl' 'smr' }; % types of analysis
rawdatafile='SsmrData.mat'; % select raw data struct
procdatafile='SProc.mat'; % select file name for processed data  
filterband=[.0145 .015 .35 .355]; % band pass filter specs
badChanTresh=1.4; % bad channel threshold
badTrTresh=.9; % bad trial threshold
trLength=[-10 35]; % start and end of trial window
baseEvents=7; % for removal of the first no movement trial
visual=1; % show figures
totalgr=0; % plot total grand average
savefig=0; % save figures
savedat=1; % save data
% save option info for annotating figures
info={strcat('badCh: ',num2str(badChanTresh)) strcat('badTr:',num2str(badTrTresh))
...
strcat('filt:',num2str(filterband(2)),'-',num2str(filterband(3)))};
%% START %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
fprintf('Loading data...\n')
load(strcat('~/workspace/analysisData/',rawdatafile));
if(strcmp(names{1},'all')) names=fieldnames(raw); end % loop through all subjects
names([1 2])=[]; %exclude the first two subjects, no EEG data
%loop through types of analysis
for j=1:numel(types)
type=types{j};
%loop through subjects
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for i=1:numel(names)
close all
clear subject subtraction config data devents state xmlInfo OD
subject=names{i};
fprintf('Processing subject %s type %s\n',names{i},type);
switch type
case 'offl' % offline NIRS analysis
config=raw.(subject).bold.info.config; % extract optode config
devents=raw.(subject).bold.devents; % extract event info
xmlInfo=raw.(subject).xmlInfo; % extract xml info 
template=raw.(subject).bold.info.template; % extract optode 
template
OD=raw.(subject).OD; % extract raw data
mkpreproc; % run analysis script
case 'smr' % offline EEG analysis
if (isempty(fieldnames(raw.(subject).(type))))
fprintf('No smr data, continue to next\n');
continue
end
capFile='cap_tmsi_mk'; % file containing EEG electrode 
location
thresh=[.0 .1 .2 5]; % bad trial threshold
badchThresh=1e-4; % bad channel threshold
overridechnms=1; % override channel names
data=raw.(subject).(type).data; % extract raw data
devents=raw.(subject).(type).devents; % extract event info
state=raw.(subject).(type).state; % extract header info
%remove first no movement trial
devents(1:7:end)=[];
data(1:7:end)=[];
cond=[devents.value];
%remove baseline data
for k=1:numel(data)
data(k).buf(:,1:5*state.hdr.fsample)=[];
end
% run analysis of EEG data, hand movement vs no movement
[C3smrclsfr,C3smrRes]=buffer_train_ersp_clsfr(data(cond==1|cond==3
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),...
devents(cond==1|cond==3),state.hdr,...
'spatialfilter','car','freqband',[6 10 26 30],'badchrm',1,...
'badtrrm',1,'objFn','lr_cg','compKernel',0,'dim',3,'capFile',
capFile,...
'overridechnms',overridechnms,'visualize',visual,'cog',1);
% run analysis of EEG data, foot movement vs no movement
[C2smrclsfr,C2smrRes]=buffer_train_ersp_clsfr(data(cond==1|cond==2
),...
devents(cond==1|cond==2),state.hdr,...
'spatialfilter','car','freqband',[6 10 26 30],'badchrm',1,...
'badtrrm',1,'objFn','lr_cg','compKernel',0,'dim',3,'capFile',
capFile,...
'overridechnms',overridechnms,'visualize',visual,'cog',1);
if(savefig || savedat)
mksave; % save figures and data
end
end
message = sprintf('Click the OK button to continue');
uiwait(msgbox(message));
end
end
if(totalgr) totalgrand; end
fprintf('Finished\n');
-3-
E.3 fNIRS specific analysis script
109
mkpreproc.m
%% Control script for analysing NIRS data
% Magnus L. R. Krogh
clear grand med chanAvg avg procdat cldatC2 cldatC3
% channel names and positions
chNames={'Rx1-Tx1' 'Rx1-Tx2' 'Rx1-Tx3' 'Rx1-Tx4'...
'Rx2-Tx1' 'Rx2-Tx2' 'Rx2-Tx3' 'Rx2-Tx4'};
chPos=[5 5 7 7 3 3 1 1;3.3 1.1 3.3 1.1 3.3 1.1 3.3 1.1];
%% DATA PROCESSING %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
fprintf('Processing NIRS data, %d trials ...\n', numel(data));
onl.xmlInfo=xmlInfo;
onl.xmlInfo.nbSamples=25/onl.xmlInfo.SampleTime;
cond=[devents.value];
switch type
case 'bold' % for processing online data, not used
[classdat,O2Hb,HHb]=preproc(data,onl.xmlInfo,'template',template,...
'badChanTresh',badChanTresh,'filterband',filterband);
case 'offl' % processing offline data
[classdat,O2Hb,HHb,badCh]=preprocOffl(OD,devents,xmlInfo,'template',...
template,'badChanTresh',badChanTresh,'filterband',filterband,...
'trLength',trLength,'baseEv',baseEvents,'seqBase',seqBase);
end
cond(1:baseEvents:end)=[]; % remove first no movement events
chNames(badCh)=[]; % remove bad channel names
chPos(:,badCh)=[]; % remove bad channel position
%% DATA AVERAGING %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
% average of all channels for each trial (1 x nS x nTr)
avg={mean(O2Hb,1) mean(HHb,1) cond};
% remove bad trials
if(~isempty(badTrTresh))
fprintf('4. Removing bad trials, ');
badTr=false(1,numel(cond));
idO=idOutliers(avg{1},3,badTrTresh);
badTr=idO;
avg{1}(:,:,badTr)=[];
avg{2}(:,:,badTr)=[];
avg{3}(badTr)=[];
cond(badTr)=0;
fprintf('%d trials removed\n',sum(badTr));
end
% calculate median, grand average and channel average
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med= {median(O2Hb(:,:,~badTr))...
median(HHb(:,:,~badTr))...
avg{3}};
grand= {mean(avg{1}(:,:,avg{3}==1),3)... % no movement, O2Hb
mean(avg{2}(:,:,avg{3}==1),3)... % no movement, HHb
mean(avg{1}(:,:,avg{3}==2),3)... % foot movement, O2Hb
mean(avg{2}(:,:,avg{3}==2),3)... % foot movement, HHb
mean(avg{1}(:,:,avg{3}==3),3)... % hand movement, O2Hb
mean(avg{2}(:,:,avg{3}==3),3)}; % hand movement, HHb
chanAvgO=cat(3,mean(O2Hb(:,:,avg{3}==1),3),...
mean(O2Hb(:,:,avg{3}==2),3),...
mean(O2Hb(:,:,avg{3}==3),3));
chanAvgH=cat(3,mean(HHb(:,:,avg{3}==1),3),...
mean(HHb(:,:,avg{3}==2),3),...
mean(HHb(:,:,avg{3}==3),3));
fprintf('5. Training classifier.\n');
st=onl.xmlInfo.SampleTime; % sample time
%% CLASSIFIER TRAINING %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%% hand movement classifier %%%%%
% concatenate data for classification
cldatC3=cat(3,classdat(:,:,cond==1),classdat(:,:,cond==3));
%cut away pre- and post trial
cldatC3(:,1:(-trLength(1)+3)/st,:)=[];
cldatC3(:,end-((trLength(2)-18)/st)+1:end,:)=[];
%split into 3s segments
cldatC3=reshape(cldatC3,size(cldatC3,1),size(cldatC3,2)/5,size(cldatC3,3)*5);
labels=[-ones(1,sum(cond==1)*5) ones(1,sum(cond==3)*5)]; % class labels
% train classifier
[C3clsfr, C3res]=cvtrainLinearClassifier(cldatC3,labels);
% extract optimal classification
C3clfrate=C3res.tstbin(:,:,C3res.opt.Ci);
fprintf('\n\nClassification rate: %6.2f\n',C3clfrate);
%% foot movement classifier %%%%%%
clear labels
% concatenate data for classification
cldatC2=cat(3,classdat(:,:,cond==1),classdat(:,:,cond==2));
%cut away pre- and post task
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cldatC2(:,1:(-trLength(1)+3)/st,:)=[];
cldatC2(:,end-((trLength(2)-18)/st)+1:end,:)=[];
%split into 3s segments
cldatC2=reshape(cldatC2,size(cldatC2,1),size(cldatC2,2)/5,size(cldatC2,3)*5);
labels=[-ones(1,sum(cond==1)*5) ones(1,sum(cond==2)*5)]; % class labels
% train classifier
[C2clsfr, C2res]=cvtrainLinearClassifier(cldatC2,labels,[],10);
% extract optimal classification
C2clfrate=C2res.tstbin(:,:,C2res.opt.Ci);
fprintf('\n\nClassification rate: %6.2f\n',C2clfrate);
%% PLOTTING
if(visual) mkplot; end
%% SAVING
if(savefig || savedat) mksave; end
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preprocOffl.m
function [unproc,O2Hb,HHb,badCh] = preprocOffl(OD,devents,xmlInfo,varargin)
% Function for processing and analysing NIRS signals
% Magnus L. R. Krogh
%
% Inputs:
%  dat         - (struct) dataset from field trip buffer
%  marks       - (1 x nMarks) sample number markers
%
% Outputs:
%  unproc    - unbaselined data for the classifier
%  O2Hb    - processed oxygenated hemoglobin data
%  HHb    - processed deoxygenated hemoglobin data
%  badCh    - bad channel identification
%
% Options:
%  template    - [subtemplate, Rx, Tx] template used recording NIRS
%  filterband  - [highpass lowpass] filter frequency band ([0.01 0.35])
%  baseline    - (int) seconds of baseline (5)
%  badChanThresh  - [tresh] remove bad channels, no removal if empty
%  trLength    - [start end] length of trial in seconds
%  baseEv    - (int) remove the first trail in each sequence
%  detrend    - (bool) detrend data
Rx1=1; Rx2=2; Tx1=[1,2]; Tx2=[3,4]; Tx3=[5,6]; Tx4=[7,8];
opts=struct('template',...
[1 Rx1 Tx1;...
2 Rx1 Tx2;...
3 Rx1 Tx3;...
4 Rx1 Tx4;...
5 Rx2 Tx1;...
6 Rx2 Tx2;...
7 Rx2 Tx3;...
8 Rx2 Tx4],...
'filterband',[0.0001 0.01 .35 .355],'baseline',5,'badChanTresh',[],...
'filt',[],'trLength',[-5 20],'baseEv',7,'detrend',1);
% merge input options with default
[opts,varargin]=parseOpts(opts,varargin);
template=opts.template;
filterband=opts.filterband;
baseline=opts.baseline;
badChanTresh=opts.badChanTresh;
trLength=opts.trLength;
baseEv=opts.baseEv;
detr=opts.detrend;
% variables
st=xmlInfo.SampleTime; % sample time
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trDur=trLength(2)-trLength(1); % trial duration
marks=[devents.sample]; % event markers
baseMarks=marks(1:baseEv:end); % markers for first trail in each 
sequence
marks(1:baseEv:end)=[];; % remove first markers in each sequence
nT=numel(marks); % number of trials
marks=marks+((trLength(1)+baseline)/st); % move markers to fit trial duration
% convert optical density to hemoglobin changes
fprintf('1. Converting to hemoglobin changes\n');
for l=1:size(template,1)
[q,tmpO(l,:),tmpH(l,:)]=single_ch(OD,xmlInfo,1,template(l,2),template(l,3:4));
end
% remove start and end of data stream
tmpO(:,marks(end)+(trDur/st)+2:end)=[];
tmpH(:,marks(end)+(trDur/st)+2:end)=[];
badCh=false(8,1); % set bad channel identification to false
% remove bad channels
if(~isempty(badChanTresh))
fprintf('2. Removing bad channels, ');
idO=idOutliers(tmpO,1,badChanTresh); % identify bad channels
badCh=idO;
tmpO(badCh,:)=[];
tmpH(badCh,:)=[];
fprintf('%d channels removed\n',sum(badCh));
end
% filter data stream
if(~isempty(filterband))
fs=250;
len=size(tmpO,2);
filt=mkFilter(filterband,floor(len/2),fs/len);
tmpO=fftfilter(tmpO,filt,[],2);
tmpH=fftfilter(tmpH,filt,[],2);
end
% slice into trials
for i=1:nT
O2Hb(:,:,i)=tmpO(:,marks(i)+1:marks(i)+trDur/st);
HHb(:,:,i)=tmpH(:,marks(i)+1:marks(i)+trDur/st);
end
% return unbaselined data for the classifier
unproc=cat(1,O2Hb,HHb);
% detrend data, only if trial window is symmetrical around BOLD response
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if(detr && trDur>44)
fprintf('3. Detrending\n');
O2Hb=detrend(O2Hb,2);
HHb=detrend(HHb,2);
end
%subtract baseline
O2Hb=bsxfun(@minus,O2Hb,mean(O2Hb(:,(-trLength(1)-baseline)/st+1:...
-trLength(1)/st,:),2));
HHb=bsxfun(@minus,HHb,mean(HHb(:,(-trLength(1)-baseline)/st+1:...
-trLength(1)/st,:),2));
end
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mkcognirs.m
%% Script for calculating and plotting CoG for NIRS
% Magnus L. R. Krogh
% load data
procdatafile='SProc.mat';
load(strcat('~/workspace/analysisData/',procdat));
% variables
trLength=[-10 35]; % length of trial window
st=0.004; % sampling time
visual=1; % visualize output
names=fieldnames(mk); % extract subject names (S1, S2, S3 ...)
for i=1:numel(names) % loop through subjects
clear x y a3H a2H a3O a3H
subj=names{i};
chAvgO=mk.(subj).offl.chanAvgO.OHb; % channel average, O2Hb (ch x data x cond)
chAvgH=mk.(subj).offl.chanAvgO.HHb; % channel average, HHb (ch x data x cond)
x=mk.(subj).offl.chPos(1,:)'; % channel position
y=mk.(subj).offl.chPos(2,:)'; % channel position
% calculate CoG
a3O=abs(mean(chAvgO(:,-trLength(1)/st:(-trLength(1)+15)/st,3),2));
a2O=abs(mean(chAvgO(:,-trLength(1)/st:(-trLength(1)+15)/st,2),2));
a3H=abs(mean(chAvgH(:,-trLength(1)/st:(-trLength(1)+15)/st,3),2));
a2H=abs(mean(chAvgH(:,-trLength(1)/st:(-trLength(1)+15)/st,2),2));
cog(:,:,i)=[sum(x.*a3O)/sum(a3O) sum(y.*a3O)/sum(a3O);... % hand O2Hb
sum(x.*a3H)/sum(a3H) sum(y.*a3H)/sum(a3H);... % hand HHb
sum(x.*a2O)/sum(a2O) sum(y.*a2O)/sum(a2O);... % foot O2Hb
sum(x.*a2H)/sum(a2H) sum(y.*a2H)/sum(a2H)]; % foot HHb
% save CoG
mk.(subj).offl.cog=cog(:,:,i);
end
%% plot CoG
if(visual)
cog=mean(cog,3); % average CoG for all subjects
figure(1);
suptitle('Center of gravity for hand and foot movement');
scatter(cog(1,1),cog(1,2),'fill','d','r');
axis equal;
axis([-.5 8.5 -.5 5]);
set(gca,'YTick',[0 1.1 2.2 3.3 4.4]);
grid on;
hold on;
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scatter(cog(2,1),cog(2,2),'fill','d','b');
hold on;
scatter(cog(3,1),cog(3,2),'fill','S','r');
hold on;
scatter(cog(4,1),cog(4,2),'fill','S','b');
l=legend('Hand O2','Hand H','Foot O2','Foot H');
legend(l,'boxoff');
xlabel('X [cm]');
ylabel('Y [cm]');
% visualize optode placement locations
r=.2;
px=[0 4 8 0 4 8]; py=[0 0 0 4.4 4.4 4.4];
hold on;
rectangle('Position',[2-r 2.2-r r*2 r*2],'Curvature',1,'FaceColor',[0 0 0]);
hold on;
rectangle('Position',[6-r 2.2-r r*2 r*2],'Curvature',1,'FaceColor',[0 0 0]);
text(8,2.2,'CZ','VerticalAlignment','Middle','HorizontalAlignment','Center');
text(4,2.2,'C3','VerticalAlignment','Middle','HorizontalAlignment','Center');
for i=1:6
hold on;
rectangle('Position',[px(i)-r py(i)-r r*2 r*2],'Curvature',1,...
'FaceColor',[0.8 0.8 0.8]);
end
end
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grandfinal.m
%% Script for plotting total grand average over all subjects, NIRS
% Magnus L. R. Krogh
% load processed data file and run
names=fieldnames(mk);
type='offl';
trLength=[-5 25];
st=0.004;
% load averages
for i=1:numel(names)
c1.O2Hb(i,:)=mk.(names{i}).(type).grand{1};
c1.HHb(i,:)=mk.(names{i}).(type).grand{2};
c2.O2Hb(i,:)=mk.(names{i}).(type).grand{3};
c2.HHb(i,:)=mk.(names{i}).(type).grand{4};
c3.O2Hb(i,:)=mk.(names{i}).(type).grand{5};
c3.HHb(i,:)=mk.(names{i}).(type).grand{6};
C3clfr(i)=mk.(names{i}).(type).clsfr.C3.clfrate;
C2clfr(i)=mk.(names{i}).(type).clsfr.C2.clfrate;
end
C3rate=mean(C3clfr);
C2rate=mean(C2clfr);
sD=[(10+trLength(1))/st+1 (10+trLength(2))/st];
% grand average
c1.grand.O2Hb=mean(c1.O2Hb(:,sD(1):sD(2)));
c1.grand.HHb=mean(c1.HHb(:,sD(1):sD(2)));
c2.grand.O2Hb=mean(c2.O2Hb(:,sD(1):sD(2)));
c2.grand.HHb=mean(c2.HHb(:,sD(1):sD(2)));
c3.grand.O2Hb=mean(c3.O2Hb(:,sD(1):sD(2)));
c3.grand.HHb=mean(c3.HHb(:,sD(1):sD(2)));
%% plot
st=0.004;
t=trLength(1)+st:st:trLength(2);
scale=[trLength -.5 .5];
tx=[t,fliplr(t)];
% Margin of error, one standard deviation
c1ErrO2=std(c1.O2Hb(:,sD(1):sD(2)));
c1ErrHb=std(c1.HHb(:,sD(1):sD(2)));
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c2ErrO2=std(c2.O2Hb(:,sD(1):sD(2)));
c2ErrHb=std(c2.HHb(:,sD(1):sD(2)));
c3ErrO2=std(c3.O2Hb(:,sD(1):sD(2)));
c3ErrHb=std(c3.HHb(:,sD(1):sD(2)));
Y1=[c1.grand.O2Hb,fliplr(c1.grand.O2Hb+c1ErrO2)];
Y2=[c2.grand.O2Hb,fliplr(c2.grand.O2Hb+c2ErrO2)];
Y3=[c1.grand.HHb-c1ErrHb,fliplr(c1.grand.HHb)];
Y4=[c2.grand.HHb-c2ErrHb,fliplr(c2.grand.HHb)];
Y5=[c3.grand.O2Hb,fliplr(c3.grand.O2Hb+c3ErrO2)];
Y6=[c3.grand.HHb-c3ErrHb,fliplr(c3.grand.HHb)];
% total grand
str1=strcat('Clfrate: ',num2str(C3rate));
str2=strcat('Clfrate: ',num2str(C2rate));
h8=figure(6);
clf; set(h8, 'PaperUnits','centimeters','PaperPosition', [0 0 21 7]);
subplot(1,3,1);
fill(tx,Y5,'b',tx,Y6,'g');
hold on;
plot(t,c3.grand.O2Hb,'k','LineWidth',2);
hold on;
plot(t,c3.grand.HHb,'k','LineWidth',2);
axis(scale);
title('Hand movement');
xlabel('Time [s]');
ylabel('\Delta chromophore');
yL = get(gca,'YLim');
subplot(1,3,2);
fill(tx,Y2,'b',tx,Y4,'g');
hold on;
plot(t,c2.grand.O2Hb,'k','LineWidth',2);
hold on;
plot(t,c2.grand.HHb,'k','LineWidth',2);
axis(scale);
title('Foot movement');
subplot(1,3,3);
fill(tx,Y1,'b',tx,Y3,'g');
hold on;
plot(t,c1.grand.O2Hb,'k','LineWidth',2);
hold on;
plot(t,c1.grand.HHb,'k','LineWidth',2);
axis(scale);
title('No movement');
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%save
dir='~/workspace/archive/analysis/';
stamp=datestr(clock,'yymmdd-HHMM-');
saveas(h8,strcat(dir,stamp,'S-totGrand'),'png');
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mksave.m
%% Script for saving processed data in directory structure
% Magnus L. R. Krogh
dir=strcat('~/workspace/archive/analysis/'); % directory for saving
% check if directory exists, if not create it
if (exist(dir,'dir')==0)
fprintf('Creating directory %s\n',dir);
mkdir(dir);
end
%load save stucture if it exists, if not create it
if(exist(strcat('~/workspace/analysisData/',procdatafile))==2)
load(strcat('~/workspace/analysisData/',procdatafile));
else
mk=struct();
save(strcat('~/workspace/analysisData/',procdatafile),'mk');
end
%% save data to struct
if(savedat)
switch type
case 'offl'
fprintf('Saving to structure\n');
mk.(subject).(type).grand=grand;
mk.(subject).(type).median=med;
mk.(subject).(type).chanAvgO=struct('OHb',chanAvgO,'HHb',chanAvgH);
mk.(subject).(type).chNames=chNames;
mk.(subject).(type).chPos=chPos;
mk.(subject).(type).clsfr.C3=struct('clfrate',C3clfrate,...
'clsfr',C3clsfr,'res',C3res);
mk.(subject).(type).clsfr.C2=struct('clfrate',C2clfrate,...
'clsfr',C2clsfr,'res',C2res);
save(strcat('~/workspace/analysisData/',procdatafile),'mk','-append');
case 'smr'
fprintf('Saving...\n');
mk.(subject).(type)=struct('capfile',capFile,...
'thresh',thresh,'badchThresh',badchThresh,'overridechnms',...
overridechnms,'C2smrclsfr',C2smrclsfr,'C2smrRes',...
C2smrRes,'C3smrclsfr',C3smrclsfr,'C3smrRes',C3smrRes);
save(strcat('~/workspace/analysisData/',procdatafile),'mk','-append');
end
end
%% save figures to archive
if(savefig)
stamp=datestr(clock,'yymmdd-HHMM-');
fprintf('Saving figures to: %s \n', dir);
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switch type
case 'offl'
saveas(h1,strcat(dir,stamp,subject,'-grand'),'jpg');
saveas(h5,strcat(dir,stamp,subject,'-avg'),'jpg');
saveas(h6,strcat(dir,stamp,subject,'-med'),'jpg');
saveas(h7,strcat(dir,stamp,subject,'-chan'),'jpg');
case 'smr'
h3=figure(1);
h4=figure(2);
saveas(h3,strcat(dir,'ERSP',stamp),'fig');
saveas(h3,strcat(dir,stamp,subject,'-ERSP'),'jpg');
saveas(h4,strcat(dir,'AUC',stamp),'fig');
saveas(h4,strcat(dir,stamp,subject,'-AUC'),'jpg');
end
end
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stimuli.m
%% Script for visual stimuli and sending events during experiments
% Magnus L. R. Krogh 
%% INITIALIZE PATHS
if ( exist('initPaths','file') )
initPaths;
else
run ~/buffer_bci/utilities/initPaths;
end
addpath(genpath('~/BCI_code/external_toolboxes/Psychtoolbox/'));
clc;
%% OPEN CONNECTION TO BUFFER
buffhost='localhost';buffport=1973;
global ft_buff; ft_buff=struct('host',buffhost,'port',buffport);
hdr=[];
% wait for the buffer to contain valid data
while ( isempty(hdr) || ~isstruct(hdr) || (hdr.nchans==0) )
try
hdr=buffer('get_hdr',[],buffhost,buffport);
catch
hdr=[];
fprintf('Invalid header info... waiting.\n');
end;
pause(1);
end;
% set the real-time-clock to use
initgetwTime();
initsleepSec();
%% BLOCK 1 BOLD/SMR  %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%% INITIALIZE VARIABLES
nSeq=6; % number of sequences
nEpoch=6; % number of trials per sequence (+1 no movement)
screen=1; % select monitor for visual stimulus, 1-monitor 
0-main
nCond=3; % number of conditions (hand, foot, no)
cueDuration=15; % cue duration (seconds)
epochDuration=1;
baseDuration=5; % baseline duration (seconds)
restDuration=[15 20]; % semi-random rest duration between values
startRest=60; % initial resting period at start of sequence
stimSeq=zeros(3,nSeq,nEpoch); % initialize stimulus sequence variable
% psychtoolbox window variables for the visual stimulus
black=0;
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white=255;
grey=150;
red=[255 10 10];
Screen('Preference','SkipSyncTests', 1); % skip syncing since it's not important
[wPtr,wrect]=Screen('OpenWindow', screen, black); % full screen monitor
Screen(wPtr,'TextFont' ,'Calibri'); % set font
Screen('TextSize', wPtr, 24); % set font size
circle=[wrect(3)/2-20 wrect(4)/2-20 wrect(3)/2+20 wrect(4)/2+20]; % make cirle
line=(.55:.04:1)*wrect(4); % lines for where the text will appear
%% START VISUAL STIMULUS %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
Screen('FillOval',wPtr,grey,circle);
Screen('DrawText', wPtr, 'Please keep your eyes on the dot during the trials.'...
,wrect(3)*0.24 ,line(1) ,white);
Screen('DrawText', wPtr, 'Say when you are ready to start the experiment.'...
,wrect(3)*0.24 ,line(2) ,white);
Screen('Flip',wPtr);
%%
waitforbuttonpress;
if(nCond<3)
%make random stimulus sequence
stimTemp=zeros(nSeq*nEpoch,1);
stimSeqFull=mkStimSeqRand(nEpoch*nSeq,(nEpoch+1)*nSeq/nCond);
for sti=1:(nEpoch+1)*nSeq/nCond
stimTemp=stimTemp|stimSeqFull(:,sti);
end
stimSeq=reshape(stimTemp,nEpoch,nSeq);
else
for i=1:nEpoch
stimSeq(:,:,i)=mkStimSeqRand(nCond,nSeq);
end
end
%%
for si=1:nSeq % loop through sequences
Screen('FillOval',wPtr,red,circle);
Screen('DrawText', wPtr, 'Do not move' ,wrect(3)*0.43 ,line(1) ,white);
Screen('Flip',wPtr);
sleepSec(15);
% send event with condition 1 (no movement) to both buffers
sendEvent('smr.epoch',1); % NIRS data buffer
sendEvent('smr.epoch',1,-1,0,0,buffhost,1972); % EEG data buffer
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sleepSec(cueDuration+11); % wait
for ei=1:nEpoch % loop through trials
cond=find(stimSeq(:,si,ei)>0);
fprintf('Seq nr: %d, Trial nr: %d, Stimcode: %d\n', si, ei, cond);
% send event with random condition to both buffers
sendEvent('smr.epoch',cond);
sendEvent('smr.epoch',cond,-1,0,0,buffhost,1972);
% baseline cue
Screen('FillOval',wPtr,grey,circle);
Screen('DrawText', wPtr, 'Do not move' ,wrect(3)*0.425 ,line(1) ,white);
Screen('Flip',wPtr);
sleepSec(baseDuration);
% movement condition cue
if (cond==3) %movement condition hand
Screen('FillOval',wPtr,red,circle);
Screen('DrawText', wPtr, 'Tap your fingers' ,wrect(3)*0.41 ,line(1) ,
white);
Screen('Flip',wPtr);
sleepSec(cueDuration);
Screen('FillOval',wPtr,grey,circle);
Screen('DrawText', wPtr, 'Rest' ,wrect(3)*0.475 ,line(1) ,white);
Screen('Flip',wPtr);
sleepSec(randi(restDuration,1,1));
elseif (cond==2) % movement condition feet
Screen('FillOval',wPtr,red,circle);
Screen('DrawText', wPtr, 'Move your toes',wrect(3)*0.425,line(1),white);
Screen('Flip',wPtr);
sleepSec(cueDuration);
Screen('FillOval',wPtr,grey,circle);
Screen('DrawText', wPtr, 'Rest' ,wrect(3)*0.475 ,line(1) ,white);
Screen('Flip',wPtr);
sleepSec(randi(restDuration,1,1));
else % no movement
Screen('FillOval',wPtr,red,circle);
Screen('DrawText', wPtr, 'Do not move' ,wrect(3)*0.425 ,line(1) ,white);
Screen('Flip',wPtr);
sleepSec(cueDuration);
Screen('FillOval',wPtr,grey,circle);
Screen('DrawText', wPtr, 'Rest' ,wrect(3)*0.475 ,line(1) ,white);
Screen('Flip',wPtr);
sleepSec(5);
end
end
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if(si<nSeq) % break between sequences
Screen('FillOval',wPtr,grey,circle);
Screen('DrawText',wPtr,...
'Say when you are ready to start the next sequence.',...
wrect(3)*0.24 ,line(1) ,white);
Screen('Flip',wPtr);
waitforbuttonpress;
end
end
% send event ending data recording
sendEvent('smr.recording', 'end');
sendEvent('smr.recording','end',-1,0,0,buffhost,1972);
Screen('DrawText', wPtr, 'Thank you very much for participating.',...
wrect(3)*0.2 ,line(5) ,white);
Screen('Flip',wPtr);
waitforbuttonpress;
sca;
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nirsSigProc.m
%% NIRS signal processing script which saves measured data online
% Magnus L. R. Krogh
%% INITIALIZE PATHS
if ( exist('initPaths','file') )
initPaths;
else
run ~/buffer_bci/utilities/initPaths;
end
%% OPEN CONNECTION TO BUFFER
buffhost='localhost';buffport=1973;
global ft_buff; ft_buff=struct('host',buffhost,'port',buffport);
% wait for the buffer to return valid header information
hdr=[];
while ( isempty(hdr) || ~isstruct(hdr) || (hdr.nchans==0) )
try
hdr=buffer('get_hdr',[],buffhost,buffport);
catch
hdr=[];
fprintf('Invalid header info... waiting.\n');
end;
pause(1);
end;
% set the real-time-clock to use
initgetwTime();
initsleepSec();
%% INITIALIZE SAVE STRUCTURE
if(~exist('subject','var'))
subject=input('Enter subject name\n','s');
end
fprintf('Starting signal processing script on subject %s\n',subject);
datadir=strcat('~/workspace/data/',subject,'/');
% test if directory exists, if not create it
if(exist(datadir)==0)
mkdir(datadir);
end
%% VARIABLES
b1_ms=25000; % duration of recording from each event (ms)
b1name='BOLDdata'; % name of saved data structure
%%
%% BLOCK 1 (BOLD)
fprintf('Start recording block 1 ...\n');
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% data recording function, waits for events to start recording
[b1data,b1devents,b1state]=buffer_waitData(buffhost,buffport,[],'startSet',...
{'smr.epoch'},'trlen_ms',b1_ms,'exitSet',{'smr.recording' 'end'});
% remove last "end recording" event
mi=matchEvents(b1devents,'smr.recording','end'); b1devents(mi)=[]; b1data(mi)=[];
% save data
fprintf('Saving %d epochs to : %s\n',numel(b1devents),strcat(datadir,b1name));
save(strcat(datadir,b1name),'b1data','b1devents','b1state');
%%
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%% EEG signal processing script which saves measured data online
% Magnus L. R. Krogh
%% INITIALIZE PATHS
if ( exist('initPaths','file') )
initPaths;
else
run ~/buffer_bci/utilities/initPaths;
end
%% OPEN CONNECTION TO BUFFER
buffhost='localhost';buffport=1972;
global ft_buff; ft_buff=struct('host',buffhost,'port',buffport);
% wait for the buffer to return valid header information
hdr=[];
while ( isempty(hdr) || ~isstruct(hdr) || (hdr.nchans==0) )
try
hdr=buffer('get_hdr',[],buffhost,buffport);
catch
hdr=[];
fprintf('Invalid header info... waiting.\n');
end;
pause(1);
end;
% set the real-time-clock to use
initgetwTime();
initsleepSec();
%% INITIALIZE SAVE STRUCTURE
if(~exist('subject','var'))
subject=input('Enter subject name\n','s');
end
fprintf('Starting signal processing script on subject %s\n',subject);
datadir=strcat('~/workspace/data/',subject,'/');
% test if directory exists, if not create it
if(exist(datadir)==0)
mkdir(datadir);
end
%% VARIABLES
b1_ms=10000; % duration of recording from each event (ms)
b1name='SMRdata'; % name of saved data structure
%%
%% BLOCK 1 (smr)
fprintf('Start recording block 1 ...\n');
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% data recording function, waits for events to start recording
[b1data,b1devents,b1state]=buffer_waitData(buffhost,buffport,[],'startSet',...
{'smr.epoch'},'trlen_ms',b1_ms,'exitSet',{'smr.recording' 'end'});
% remove last "end recording" event
mi=matchEvents(b1devents,'smr.recording','end'); b1devents(mi)=[]; b1data(mi)=[];
% save data
fprintf('Saving %d epochs to : %s\n',numel(b1devents),strcat(datadir,b1name));
save(strcat(datadir,b1name),'b1data','b1devents','b1state');
%%
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MATLAB scripts and functions
developed at Donders Inst.
These scripts and functions are released under the GNU General Public
License for open source software by Dr. Jason Farquhar. These tools can
be found at www.github.com/jadref/buffer_bci.
F.1 Shell script to start buffer
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startBuffer.sh
#!/bin/bash
buffdir=`dirname $0`
bciroot=~/output
subject='test';
if [ $# -gt 0 ]; then subject=$1; fi
session=`date +%y%m%d`
if [ $# -gt 1 ]; then session=$2; fi
block=`date +%h%m`_$$
if [ $# -gt 2 ]; then block=$2; fi
outdir=$bciroot/$subject/$session/$block/raw_buffer
logfile=$bciroot/$subject/$session/$block.log
echo outdir: $outdir
echo logfile : $logfile
mkdir -p $bciroot/$subject/$session/$block
touch $logfile
if [ `uname -s` == 'Linux' ]; then
buffexe=$buffdir'/buffer/bin/saving_buffer_glx32';
if [ -r $buffdir/recording ]; then
buffexe=$buffdir'/recording';
fi
if [ -r $buffdir/buffer/bin/glnx86/recording ]; then
buffexe=$buffdir'/buffer/bin/glnx86/recording';
fi
if [ -r $buffdir/buffer/glnx86/recording ]; then
buffexe=$buffdir'/buffer/glnx86/recording';
fi
else # Mac
buffexe=$buffdir'/buffer/bin/saving_buffer';
if [ -r $buffdir/buffer/bin/maci/recording ]; then
buffexe=$buffdir'/buffer/bin/maci/recording'
fi
if [ -r $buffdir/buffer/maci/recording ]; then
buffexe=$buffdir'/buffer/maci/recording'
fi
fi
$buffexe $outdir > $logfile
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detrend.m
function [X,dtm]=detrend(X,dim,order,wght,MAXEL)
% Linearly de-trend input, i.e. 0-mean and linear trends subtracted
%
% [X,dtm]=detrend(X,[dim,order,wght,MAXEL])
%
% Inputs:
%  X     -- n-d input matrix
%  dim   -- dimension of X to detrend along
%  order -- [int] order of detrending {1,2} (1)
%  wght  -- [size(X,dim),1] weighting matrix for the points in X(dim)
%  MAXEL -- max-size before we start chunking for memory savings
% Outputs:
%  X     -- detrended X
%  dtm   -- linear matrix used to detrend X
if ( nargin < 2 || isempty(dim) ) dim=find(size(X)>1,1,'first'); end;
if ( dim < 0 ) dim=ndims(X)+dim+1; end;
if ( nargin < 3 || isempty(order) ) order=1; end;
if ( nargin < 4 || isempty(wght) ) wght=1; end; wght=wght(:);
if ( nargin < 5 || isempty(MAXEL) ) MAXEL=2e6; end;
if ( order > 2 || order < 1) error('Only 1/2nd order currently'); end;
% Compute a linear detrending matrix
xb = [(1:size(X,dim))'-size(X,dim) ones(size(X,dim),1)]; % orthogonal target's to 
regress with
xbw = repop(xb,'.*',wght); % include weighting effect
dtm = inv([ xbw(:,1:end-1)'*xb(:,1:end-1) xbw(:,1:end-1)'*xb(:,end);
xbw(:,end)'*xb(:,1:end-1) xbw(:,end)'*xb(:,end)])*xbw';
szX=size(X);
[idx,chkStrides,nchks]=nextChunk([],szX,dim,MAXEL);
while ( ~isempty(idx) )
Xch = X(idx{:});
if ( order==2 )
chidx={};for d=1:ndims(Xch); chidx{d}=1:size(Xch,d); end;
Xch(chidx{1:dim-1},2:end,chidx{dim+1:end}) = diff(Xch,order-1,dim);
Xch(chidx{1:dim-1},1 ,chidx{dim+1:end}) = Xch(chidx{1:dim-1},2,chidx{dim+1
:end}); % BODGE
end
% comp scale and bias
ab = tprod(double(Xch),[1:dim-1 -dim dim+1:ndims(X)],dtm,[dim -dim],'n');
% comp linear trend
Xest= tprod(xb,[dim -dim],ab,[1:dim-1 -dim dim+1:ndims(X)],'n');
Xch = Xch-Xest; % remove linear trend
if( order==2 ) Xch=cumsum(Xch,dim); end
X(idx{:})=Xch;
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idx=nextChunk(idx,szX,chkStrides);
end
return;
%-----------------------------------------------------------------------------
function testCase()
f=cumsum(randn(1000,100)); dim=1;
clf; plot(f(:,1),'b'); hold on;
ff=detrend(f,1); % normal
ff=detrend(f,1,[],[1 zeros(1,size(f,1)-2) 1]); % weighted
ff=detrend(f,1,[],[1 ones(1,size(f,1)-2)*5e-2 1]); % weighted
ff=detrend(f,1,[],[],2000); % chunked
ff=detrend(f,1,[],mkFilter(size(f,1),[300 500])); % weighted
plot(ff(:,1),linecol());
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idOutliers.m
function [badInd,feat,threshs,stdfeat,mufeat]=idOutliers(X,dim,thresh,feat,maxIter,
verb)
% identify outlining elements in a matrix using robust variance/mean computation 
%
% [badInd,feat,threshs,stdfeat,mufeat]=idOutliers(X,dim,thresh,feat,maxIter,verb)
%
% Inputs:
%  X      -- [n-d] data to identify outling elements of
%  dim    -- dimension(s) along which to look for outlying elements
%  thresh -- [2x1] threshold in data-std-deviations std-deviations to test to remove
%            1st element is threshold above (3), 2nd is threshold below (-inf)
%  idx    -- [Nx1] or [size(X,dim) bool] sub-set of indicies along dim to consider
%  maxIter-- [int] number of times round the remove+re-compute var loop (6)
%  feat   -- [str] which feature type to use {'mu','var'}  ('var')
%  summary-- additional descriptive info
if(nargin<2 || isempty(dim) ) dim=1; end;
if(nargin<3 || isempty(thresh) ) thresh=3.5; end;
if(nargin<4 || isempty(feat) ) feat='var'; end;
if(nargin<5 || isempty(maxIter)) maxIter=3; end;
if(nargin<6 || isempty(verb) ) verb=0; end;
szX=size(X);
% compute stds over this dim
rdims = setdiff(1:ndims(X),dim);
[stds mus]=mvar(X,rdims);
stds = sqrt(abs(stds));
if ( prod(szX(rdims))==1 ) stds=mus; end; % deal with vector inputs
if ( strcmp(feat,'var') ) feat=stds; % outlying variance
elseif (strcmp(feat,'mu') ) feat=mus; % outlying mean
elseif ( isnumeric(feat) && isequal(size(feat),szX(dim)) )
feat=feat; % outlying given feature value
else error('Unrecognised feature type: %s',feat);
end
badInd=false(size(feat));
threshs=[];
for iter=1:maxIter;
% compute variance of std over this dim for the good points
mufeat(iter) = median(feat(~badInd));
stdfeat(iter) = std(feat(~badInd));
% plot(feat);hold on;plot([0;numel(feat)],[1;1]*[mufeat mufeat+stdfeat 
mufeat-stdfeat mufeat+thresh*stdfeat]);
% remove anything too far from the mean std,std
threshs(1,iter)=mufeat(iter)+thresh(1)*stdfeat(iter);
badIndi = (feat > threshs(1,iter));
if( numel(thresh)>1 ) % lower test
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threshs(2,iter)=mufeat(iter)-thresh(2)*stdfeat(iter);
badIndi = badIndi | (feat < threshs(2,iter));
end
if ( sum(badIndi|badInd) == sum(badInd) ) break; end; % no new pts added
%if(verb>0)fprintf('%d) %d removed =  
%d',iter,sum(badIndi-badInd),sum(badInd)); end;
badInd = badInd | badIndi;
end
return;
%------------------------------------------------------------
function testCase()
X=randn(1000,1);
oI=randn(size(X))>1; X(oI)=X(oI)*5;
bad=idOutliers(X);
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buffer_train_ersp_clsfr.m
function [clsfr,res]=buffer_train_ersp_clsfr(X,Y,hdr,varargin);
opts=struct('capFile','1010','overridechnms',0);
[opts,varargin]=parseOpts(opts,varargin);
if ( nargin<3 ) error('Insufficient arguments'); end;
% extract the data - from field begining with trainingData
if ( iscell(X) )
if ( isnumeric(X{1}) )
X=cat(3,X{:});
else
error('Unrecognised data format!');
end
elseif ( isstruct(X) )
X=cat(3,X.buf);
end
X=single(X);
if ( isstruct(Y) ) Y=cat(1,Y.value); end; % convert event struct into labels
fs=[];
if ( isstruct(hdr) )
if ( isfield(hdr,'channel_names') ) chNames=hdr.channel_names; end;
if ( isfield(hdr,'fsample') ) fs=hdr.fsample; end;
elseif ( iscell(hdr) && isstr(hdr{1}) )
chNames=hdr;
end
% get position info and identify the eeg channels
di = addPosInfo(chNames,opts.capFile,opts.overridechnms); % get 3d-coords
ch_pos=cat(2,di.extra.pos3d); ch_names=di.vals; % extract pos and channels names
iseeg=[di.extra.iseeg];
% call the actual function which does the classifier training
[clsfr,res]=train_ersp_clsfr(X,Y,'ch_names',ch_names,'ch_pos',ch_pos,'fs',fs,
'badCh',~iseeg,varargin{:});
return;
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function [clsfr,res]=train_ersp_clsfr(X,Y,varargin)
% train a simple ERSP (spectral power) classifer
% 
% [clsfr]=train_ersp_clsfr(X,Y,...)
%
% Inputs:
%  X         - [ ch x time x epoch ] data set
%  Y         - [ nEpoch x 1 ] set of data class labels
% Options:  (specify as 'name',value pairs, e.g. train_ersp_clsfr(X,Y,'fs',10);
%  ch_pos    - [3 x nCh] 3-d co-ordinates of the data electrodes
%              OR
%              {str} cell array of strings which label each channel in *1010 system*
%  fs        - sampling rate of the data
%  timeband  - [2 x 1] band of times to use for classification, all if empty ([])
%  freqband  - [2 x 1] or [3 x 1] or [4 x 1] band of frequencies to use
%              EMPTY for *NO* spectral filter
%  width_ms  - [float] width in millisecs for the windows in the welch spectrum 
(250)
%              estimation.  
%              N.B. the output frequency resolution = 1000/width_ms, so 4Hz with 
250ms
%  spatialfilter -- [str] one of 'slap','car','none'  ('slap')
%  badchrm   - [bool] do we do bad channel removal    (1)
%  badchthresh - [float] threshold in std-dev units to id channel as bad (3.5)
%  badtrrm   - [bool] do we do bad trial removal      (1)
%  badtrthresh - [float] threshold in std-dev units to id trial as bad (3)
%  detrend   - [bool] do we detrend the data          (1)
%  visualize - [int] visualize the data
%               0 - don't visualize
%               1 - visualize, but don't wait
%               2 - visualize, and wait for user before continuing
%  verb      - [int] verbosity level
%  ch_names  - {str} cell array of strings which label each channel
%  class_names - {str} names for each of the classes in Y in *increasing* order ([])
% Outputs:
%  clsfr  - [struct] structure contining the stuff necessary to apply the trained 
classifier
%  res    - [struct] detailed results for each fold
opts=struct('fs',[],'timeband',[],'freqband',[],'width_ms',250,'windowType',
'hanning','aveType','amp',...
'detrend',1,'spatialfilter','slap',...
'badchrm',1,'badchthresh',3.1,'badchscale',2,...
'badtrrm',1,'badtrthresh',3,'badtrscale',2,...
'ch_pos',[],'ch_names',[],'verb',0,'capFile','1010','visualize',1,...
'badCh',[],'nFold',10,'class_names',[],'cog',0);
[opts,varargin]=parseOpts(opts,varargin);
% get the sampling rate
if ( isempty(opts.fs) ) error('Sampling rate not specified!'); end;
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di=[]; ch_pos =opts.ch_pos; ch_names=opts.ch_names;
if ( iscell(ch_pos) && isstr(ch_pos{1}) ) ch_names=ch_pos; ch_pos=[]; end;
if ( isempty(ch_pos) && ~isempty(ch_names) ) % convert names to positions
di = addPosInfo(ch_names,opts.capFile); % get 3d-coords
ch_pos=cat(2,di.extra.pos3d); ch_names=di.vals; % extract pos and channels names
end
%1) Detrend
if ( opts.detrend )
fprintf('1) Detrend\n');
X=detrend(X,2); % detrend over time
end
%2) Bad channel identification & removal
isbadch=[]; chthresh=[];
if ( opts.badchrm || ~isempty(opts.badCh) )
fprintf('2) bad channel removal, ');
isbadch = false(size(X,1),1);
if ( ~isempty(opts.badCh) )
isbadch(opts.badCh)=true;
goodCh=find(~isbadch);
if ( opts.badchrm )
[isbad2,chstds,chthresh]=idOutliers(X(goodCh,:,:),1,opts.badchthresh);
isbadch(goodCh(isbad2))=true;
end
elseif ( opts.badchrm ) [isbadch,chstds,chthresh]=idOutliers(X,1,opts.badchthresh
);
end;
X=X(~isbadch,:,:);
if ( ~isempty(ch_names) ) % update the channel info
ch_pos =ch_pos(:,~isbadch(1:numel(ch_names)));
ch_names=ch_names(~isbadch(1:numel(ch_names)));
end
fprintf('%d ch removed\n',sum(isbadch));
end
%3) Spatial filter/re-reference
R=[];
if ( size(X,1)> 5 ) % only spatial filter if enough channels
switch lower( opts.spatialfilter )
case 'slap';
fprintf('3) Slap\n');
if ( ~isempty(ch_pos) )
R=sphericalSplineInterpolate(ch_pos,ch_pos,[],[],'slap');%pre-compute the 
SLAP filter we'll use
else
warning('Cant compute SLAP without channel positions!');
end
case 'car';
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fprintf('3) CAR\n');
R=eye(size(X,1))-(1./size(X,1));
case {'whiten','wht'};
fprintf('3) whiten\n');
R=whiten(X,1,1,0,0,1); % symetric whiten
case 'none';
otherwise; warning(sprintf('Unrecog spatial filter type: %s. Ignored!',opts.
spatialfilter ));
end
end
if ( ~isempty(R) ) % apply the spatial filter
X=tprod(X,[-1 2 3],R,[1 -1]);
end
%2.2) time range selection
timeIdx=[];
if ( ~isempty(opts.timeband) )
timeIdx = opts.timeband * fs; % convert to sample indices
timeIdx = max(min(timeIdx,size(X,2)),1); % ensure valid range
X = X(:,timeIdx(1):timeIdx(2),:);
end
%2.5) Bad trial removal
if ( opts.badtrrm )
fprintf('2) bad trial removal');
[isbadtr,trstds,trthresh]=idOutliers(X,3,opts.badtrthresh);
X=X(:,:,~isbadtr);
Y=Y(~isbadtr);
fprintf(' %d tr removed\n',sum(isbadtr));
end;
%4) welch to convert to power spectral density
fprintf('4) Welch\n');
[X,wopts,winFn]=welchpsd(X,2,'width_ms',opts.width_ms,'windowType',opts.windowType,
'fs',opts.fs,...
'aveType',opts.aveType,'detrend',1);
freqs=0:(1000/opts.width_ms):opts.fs; % position of the frequency bins
%5) sub-select the range of frequencies we care about
fidx=[];
if ( ~isempty(opts.freqband) && size(X,2)>10 && ~isempty(opts.fs) )
if ( numel(opts.freqband)>2 ) % convert the diff band spects to upper/lower 
frequencies
if ( numel(opts.freqband)==3 ) opts.freqband=opts.freqband([1 3]);
elseif(numel(opts.freqband)==4 ) opts.freqband=[mean(opts.freqband([1 2])) mean
(opts.freqband([3 4]))];
end
end
fprintf('5) Select frequencies\n');
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[ans,fidx(1)]=min(abs(freqs-opts.freqband(1))); % lower frequency bin
[ans,fidx(2)]=min(abs(freqs-opts.freqband(2))); % upper frequency bin
X=X(:,fidx(1):fidx(2),:); % sub-set to the interesting frequency range
end;
%5.5) Visualise the input?
if ( opts.visualize && ~isempty(ch_pos) )
uY=unique(Y);sidx=[]; labels=opts.class_names;
for ci=1:numel(uY);
mu(:,:,ci)=mean(X(:,:,Y==uY(ci)),3);
if(~(ci>1 && numel(uY)<=2)) [auc(:,:,ci),sidx]=dv2auc((Y==uY(ci))*2-1,X,3,
sidx); end;
if ( isempty(labels) || numel(labels)<ci || isempty(labels{ci}) ) labels{ci
}=sprintf('%d',uY(ci)); end;
end
if ( ~isempty(di) ) xy=cat(2,di.extra.pos2d); % use the pre-comp ones if there
else xy = xyz2xy(ch_pos);
end
if (size(ch_pos,1)==3 ) xy = xyz2xy(ch_pos); else xy=[]; end; % convert 3d->2d 
co-ords
erpfig=figure('Name','Data Visualisation: ERSP');
yvals=freqs; if( ~isempty(fidx) ) yvals=freqs(fidx(1):fidx(2)); end
image3d(mu,1,'plotPos',xy,'Xvals',ch_names,'ylabel','freq(Hz)','Yvals',yvals,
'zlabel','class','Zvals',labels,'disptype','plot','ticklabs','sw','clabel','db');
zoomplots;
aucfig=figure('Name','Data Visualisation: ERSP AUC');
image3d(auc,1,'plotPos',xy,'Xvals',ch_names,'ylabel','freq(Hz)','Yvals',yvals,
'zlabel','class','Zvals',labels,'disptype','imaget','ticklabs','sw','clim',[.2
.8],'clabel','auc');
colormap ikelvin; zoomplots;
drawnow;
end
%custom, calculate Center of Gravity based on relative ERD, Magnus Krogh
if(opts.cog)
if(~exist('mu','var')) %check if mu has been calculated
uY=unique(Y);sidx=[]; labels=opts.class_names;
for ci=1:numel(uY);
mu(:,:,ci)=mean(X(:,:,Y==uY(ci)),3);
if(~(ci>1 && numel(uY)<=2)) [auc(:,:,ci),sidx]=dv2auc((Y==uY(ci))*2-1,X,3,
sidx); end;
if ( isempty(labels) || numel(labels)<ci || isempty(labels{ci}) ) labels{
ci}=sprintf('%d',uY(ci)); end;
end
if ( ~isempty(di) ) xy=cat(2,di.extra.pos2d); % use the pre-comp ones if there
else xy = xyz2xy(ch_pos);
end
if (size(ch_pos,1)==3 ) xy = xyz2xy(ch_pos); else xy=[]; end; % convert 
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3d->2d co-ords
end
relERD=((mean(mu(:,:,2),2)-mean(mu(:,:,1),2))./mean(mu(:,:,1),2))';
cW=1-relERD;
cW(cW>1)=0;
l=find(xy(1,:)<=0.00001); r=find(xy(1,:)>=0);
cL=[sum(xy(1,l).*cW(l))/sum(cW(l)),sum(xy(2,l).*cW(l))/sum(cW(l))]; %Left 
hemisphere only
cR=[sum(xy(1,r).*cW(r))/sum(cW(r)),sum(xy(2,r).*cW(r))/sum(cW(r))]; %Right 
hemisphere only
cB=[sum(xy(1,:).*cW)/sum(cW),sum(xy(2,:).*cW)/sum(cW)]; %Both hemispheres
cogfig=figure('Name','Data Visualisation: CoG');
axis equal;
grid on;
axis([-2 2 -2 2]);
hold on; scatter(cL(1),cL(2),'fill','d','b');
hold on; scatter(cR(1),cR(2),'fill','d','r');
hold on; scatter(cB(1),cB(2),'fill','d','g');
r=.1;
for i=1:size(ch_pos,2)
hold on;
rectangle('Position',[xy(1,i)-r xy(2,i)-r r*2 r*2],'Curvature',1);
text(xy(1,i),xy(2,i),ch_names{i},'VerticalAlignment','Middle',
'HorizontalAlignment','Center');
end
end
%6) train classifier
fprintf('6) train classifier\n');
[clsfr, res]=cvtrainLinearClassifier(X,Y,[],opts.nFold,'zeroLab',1,varargin{:});
%7) combine all the info needed to apply this pipeline to testing data
clsfr.fs = opts.fs; % sample rate of training data
clsfr.detrend = opts.detrend; % detrend?
clsfr.isbad = isbadch;% bad channels to be removed
clsfr.spatialfilt = R; % spatial filter used for surface laplacian
clsfr.filt = []; % DUMMY -- so ERP and ERSP classifier have same structure 
fields
clsfr.outsz = []; % DUMMY -- so ERP and ERSP classifier have same structure 
fields
clsfr.timeIdx = timeIdx; % time range to apply the classifer to
clsfr.windowFn = winFn;% temporal window prior to fft
clsfr.welchAveType= opts.aveType;% other options to pass to the welchpsd
clsfr.freqIdx = fidx; % start/end index of frequencies to keep
clsfr.badtrthresh = []; if ( ~isempty(trthresh) ) clsfr.badtrthresh = trthresh(end
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)*opts.badtrscale; end
clsfr.badchthresh = []; if ( ~isempty(chthresh) ) clsfr.badchthresh = chthresh(end
)*opts.badchscale; end
% record some dv stats which are useful
tstf = res.tstf(:,res.opt.Ci); % N.B. this *MUST* be calibrated to be useful
clsfr.dvstats.N = [sum(res.Y>0) sum(res.Y<=0) numel(res.Y)]; % [pos-class 
neg-class pooled]
clsfr.dvstats.mu = [mean(tstf(Y==clsfr.spKey(1))) mean(tstf(Y==clsfr.spKey(2)))
mean(tstf)];
clsfr.dvstats.std = [std(tstf(Y==clsfr.spKey(1))) std(tstf(Y==clsfr.spKey(2)))
std(tstf)];
%  bins=[-inf -200:5:200 inf]; clf;plot([bins(1)-1 bins(2:end-1) 
bins(end)+1],[histc(tstf(Y>0),bins) histc(tstf(Y<=0),bins)]); 
%custom
if(opts.cog)
res.CoG = struct('L',cL,'R',cR,'both',cB);
res.extra = struct('auc',auc,'mu',mu,'ch_names',{ch_names},'yvals',yvals
,'xy',xy);
end
if ( opts.visualize > 1 )
b=msgbox({sprintf('Classifier performance : %s',sprintf('%4.1f ',res.tstbin(:,:,
res.opt.Ci)*100)) 'OK to continue!'},'Results');
while ( ishandle(b) ) pause(.1); end; % wait to close auc figure
if ( ishandle(aucfig) ) close(aucfig); end;
if ( ishandle(erpfig) ) close(erpfig); end;
if ( ishandle(b) ) close(b); end;
drawnow;
end
return;
%---------------------------------
function xy=xyz2xy(xyz)
% utility to convert 3d co-ords to 2-d ones
% search for center of the circle defining the head
cent=mean(xyz,2); cent(3)=min(xyz(3,:));
f=inf; fstar=inf; tstar=0;
for t=0:.05:1; % simple loop to find the right height..
cent(3)=t*(max(xyz(3,:))-min(xyz(3,:)))+min(xyz(3,:));
r2=sum(repop(xyz,'-',cent).^2);
f=sum((r2-mean(r2)).^2); % objective is variance in distance to the center
if( f<fstar ) fstar=f; centstar=cent; end;
end
cent=centstar;
r = abs(max(abs(xyz(3,:)-cent(3)))*1.1); if( r<eps ) r=1; end; % radius
h = xyz(3,:)-cent(3); % height
rr=sqrt(2*(r.^2-r*h)./(r.^2-h.^2)); % arc-length to radial length ratio
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xy = [xyz(1,:).*rr; xyz(2,:).*rr];
return
%---------------------------------------
function testCase()
z=jf_mksfToy('Y',sign(round(rand(600,1))-.5));
[clsfr]=train_ersp_clsfr(z.X,z.Y,'fs',z.di(2).info.fs,'ch_pos',[z.di(1).extra.pos3d
],'ch_names',z.di(1).vals,'freqband',[0 .1 10 12],'visualize',1,'verb',1);
f=apply_ersp_clsfr(X,clsfr);
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function [classifier,res,Y]=cvtrainLinearClassifier(X,Y,Cs,fIdxs,varargin)
% train a regularised linear classifier with reg-parameter tuning by cross 
validation
% 
% [classifier,res]=trainLinearClassifier(X,Y,Cs,fIdxs,varargin)
%
% N.B. use applyLinearClassifier to apply the learned model to new data.
%
% Inputs:
%  X - [n-d float] the data to classify/train on
%  Y - [size(X,dim) x 1] set of 1:nSp per trial labels
%      OR
%      [size(X,dim) x nSp] set of -1/0/+1 per-subproblem labels, where 0 indicates 
an ignored point
%  Cs      - [1 x nCs] set of penalties to test                            
([10^(-3:3) 0])
%  fIdxs   - [size(Y,1) x nFold] logical matrix indicating which trials
%            to use in each fold, 
%               -1 = training trials, 0 = excluded trials,  1 = testing trials
%            OR
%            [1 x 1] number of folds to use (only for Y=trial labels).     (10)
%            or
%            [size(Y) x nFold x nCls] logical matrix indicating trials for each 
sub-prob per fold
% Options:
%  dim    - [int] the dimension(s) of X which contain the trials            
(ndims(X))
%  objFn  - [str] which objetive function to optimise,                      
('klr_cg')
%  Cscale - [float] scaling parameter for the penalties                     
(.1*var(X))
%             N.B. usually auto computed from the data, set to 1 to force input Cs  
%  balYs  - [bool] balance the labels of sets                               (0)
%  spType - [str] sub-problem decomposition to use for multi-class. one-of '1v1' 
'1vR' ('1v1')
%  spKey  - [Nx1] set of all possible label values                          ([])
%  spMx   - [nSp x nClass] encoding/decoding matrix to map from class labels 
to/from binary 
%           subProblems                                                     ([])
% Outputs:
%  classifier -- [struct] containing all the information about the linear classifier
%           |.w -- [size(X) x nSp] weighting over X (for each subProblem)
%           |.b -- [nSp x 1] bias term
%           |.dim -- [ind] dimensions of X which contain the trails
%  res   -- [struct] results structure as returned by cvtrainFn
opts=struct('objFn','klr_cg','dim',[],'spType','1v1','spKey',[],'spMx',[],'zeroLab'
,0,...
'balYs',0,'verb',0,'Cscale',[],'compKernel',1);
[opts,varargin]=parseOpts(opts,varargin);
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if( nargin < 3 ) Cs=[]; end;
if( nargin < 4 || isempty(fIdxs) ) fIdxs=10; end;
dim=opts.dim; if ( isempty(dim) ) dim=ndims(X); end;
dim(dim<0)=dim(dim<0)+ndims(X)+1; % convert negative to positive indicies
if( ndims(Y)==2 && size(Y,1)==1 && size(Y,2)>1 ) Y=Y'; end; % col vector only
% build a multi-class decoding matrix
spKey=opts.spKey; spMx =opts.spMx;
if ( ~(isempty(spKey) && isempty(spMx)) ) % sub-prob decomp already done, so trust 
it
if ( ~all(Y(:)==-1 | Y(:)==0 | Y(:)==1) )
error('spKey/spMx given but Y isnt an set of binary sub-problems');
end
elseif ( size(Y,2)==1 && all(Y(:)==-1 | Y(:)==0 | Y(:)==1) && ~(opts.zeroLab && any
(Y(:)==0)) ) % already a valid binary problem
spKey=[1 -1]; % binary problem
spMx =[1 -1];
else
[Y,spKey,spMx]=lab2ind(Y,spKey,spMx,opts.zeroLab); % convert to binary 
sub-problems
end
spDesc=mkspDesc(spMx,spKey);
% build a folding -- which is label aware, and aware of the sub-prob encoding type
if ( numel(fIdxs)==1 ) fIdxs=gennFold(Y,fIdxs,'dim',numel(dim)+1); end;
if ( opts.balYs ) [fIdxs] = balanceYs(Y,fIdxs); end % balance the folding if wanted
% estimate good range hype-params
Cscale=opts.Cscale;
if ( isempty(Cscale) || isequal(Cscale,'l2') ) Cscale=CscaleEst(X,2,[],0);
elseif ( isequal(Cscale,'l1') ) Cscale=sqrt(CscaleEst(X,2,[],0));
end
if ( isempty(Cs) ) Cs=[5.^(3:-1:-3)]; end;
oX=X; odim=dim; szX=size(X); szY=size(Y); szF=size(fIdxs);
if ( numel(dim)>1 ) % make n-d problem into 1-d problem
X=reshape(X,[prod(szX(1:min(dim)-1)) prod(szX(dim))]);
Y=reshape(Y,[prod(szY(1:numel(dim))) szY(numel(dim)+1:end) 1]);
% scale up fIdxs to Y size if necess
if ( any(szF(1:numel(dim))==1) && any(szF(1:numel(dim))~=szY(1:numel(dim))) )
fIdxs=repmat(fIdxs,[szY(1:numel(dim))./szF(1:numel(dim)) ones(1,ndims(fIdxs)-
numel(dim))]);
szF=size(fIdxs); % new size
end
fIdxs=reshape(fIdxs,[prod(szY(1:numel(dim))) szF(numel(dim)+1:end) 1]);
dim=2; % now trial dim is 2nd dimension
end
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% compute the kernel if needed for kernel methods
if ( opts.compKernel )
% compute kernel
if ( opts.verb>0 ) fprintf('CompKernel..'); end;
X = compKernel(X,[],'linear','dim',dim);
if ( opts.verb>0 ) fprintf('..done\n'); end;
% call cvtrain to do the actual work
% N.B. note we use dim 2 because of the kernel transformation
res=cvtrainFn(opts.objFn,X,Y,Cscale*Cs,fIdxs,'dim',2,'verb',opts.verb,varargin
{:});
else
% call cvtrain to do the actual work
res=cvtrainFn(opts.objFn,X,Y,Cscale*Cs,fIdxs,'dim',dim,'verb',opts.verb,varargin
{:});
end
% Extract the classifier weight vector(s)
% best hyper-parameter for all sub-probs, N.B. use the same C for all sub-probs to 
ensure multi-class is OK
[opttstbin,optCi]=max(mean(res.tstbin,2)+mean(res.tstauc,2),[],3);
for isp=1:size(Y,2); % get soln for each subproblem
if ( isfield(res,'opt') && isfield(res.opt,'soln') ) % optimal calibrated 
solution trained on all data
soln = res.opt.soln{isp};
else
soln = res.soln{isp,optCi(isp)};
end
W(:,isp) = soln(1:end-1); b(isp)=soln(end);
end
if ( ~opts.compKernel ) % input space classifier, just extract
W=reshape(W,[szX(1:min(odim)-1) size(W,2)]);
else % kernel method. extract the weights
if ( numel(odim)>1 ) W=reshape(W,[szX(odim) size(W,2)]); end;
Xidx=1:ndims(X); Xidx(odim)=-odim; % convert from dual(alpha) to primal (W)
W = tprod(oX,Xidx,W,[-odim ndims(X)+1]);
end
% put all the parameters into 1 structure
classifier = struct('W',W,'b',b,'dim',dim,'spMx',spMx,'spKey',spKey);
return;
%-----------------------------------------------------------------------------
function testCase()
[X,Y]=mkMultiClassTst([-1 0 0 0; 1 0 0 0; .2 .5 0 0],[400 400 50],[.3 .3 0 0; .3 .3
0 0; .2 .2 0 0],[],[-1 1 1]);
[classifier,res]=cvtrainLinearClassifier(X,Y,[],10);
% 2d features
X=reshape(X,[2 2 size(X,2)]);
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[classifier,res]=cvtrainLinearClassifier(X,Y,[],10);
[classifier,res]=cvtrainLinearClassifier(X,Y,[],10,'objFn','lr_cg','compKernel',0);
% non-kernel method
% 2d epochs
szX=size(X); X=reshape(X,[szX(1:end-1) szX(end)/2 2]); Y=reshape(Y,size(Y,1)/2,2);
[classifier,res]=cvtrainLinearClassifier(X,Y,[],10,'dim',[-2 -1]);
[classifier,res]=cvtrainLinearClassifier(X,Y,[],10,'objFn','lr_cg','compKernel',0,
'dim',[-2 -1]);
f=applyLinearClassifier(X,classifier);
[ans,optCi]=max(res.tstbin,[],3); % check the results are identical
clf;plot([res.f(:,1,optCi),f2(:)]);
% multi-class test
[X,Y]=mkMultiClassTst([-1 0; 1 0; .2 .5],[400 400 50],[.3 .3; .3 .3; .2 .2],[],[1 2
3]);[dim,N]=size(X);
[classifier,res]=cvtrainLinearClassifier(X,Y,[],10,'spType','1vR');
[classifier,res]=cvtrainLinearClassifier(X,Y,[],10,'spType','1v1');
fldD = n2d(res.fold.di,'fold'); spD = n2d(res.fold.di,'subProb');
cvmcPerf(Y,res.fold.f,[1 spD fldD],res.fold.di(fldD).info.fIdxs,classifier.spMx,
classifier.spKey)
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